itraconazole has been researched along with terbinafine in 504 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (1.39) | 18.7374 |
| 1990's | 106 (21.03) | 18.2507 |
| 2000's | 180 (35.71) | 29.6817 |
| 2010's | 139 (27.58) | 24.3611 |
| 2020's | 72 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, SM; Back, DJ; Tjia, JF | 1 |
| Lesher, JL | 2 |
| Back, DJ; Tjia, JF | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Dupont, B | 1 |
| Hay, RJ | 3 |
| Stevens, DA | 1 |
| Bennett, JE; Kan, VL | 1 |
| Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S | 1 |
| Cauwenbergh, G | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Bräutigam, M; Nolting, S; Schopf, RE; Weidinger, G | 2 |
| Wenig, JA | 2 |
| Neumann, HA | 1 |
| Hoeprich, PD | 1 |
| Arenas, R; Domínguez-Cherit, J; Fernández, LM | 1 |
| Clayton, YM; Hay, RJ; McGregor, JM; Ryatt, KS; Wuite, J; Ziegler, C | 1 |
| Venugopal, PV; Venugopal, TV | 1 |
| Arrese, JE; De Doncker, P; Piérard, GE | 1 |
| Leitner, I; Meingassner, JG; Mieth, H | 1 |
| Bergman, W; Rutten, FF | 1 |
| Boersma, IH; de Leeuw, J; Schuller, JL; van Zonneveld, TH | 1 |
| Roberts, DT | 1 |
| De Backer, M; De Keyser, P; Massart, DL; Westelinck, KJ | 1 |
| Basuki, J; Bramono, S; Budimulja, U; Judanarso, LS; Koesanto, D; Kuswadji, K; Untung, S; Widagdo, S | 1 |
| Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F | 1 |
| Naka, W; Nishikawa, T | 1 |
| Clayton, YM | 1 |
| De Doncker, P; Roseeuw, D | 1 |
| Degreef, H | 1 |
| Ahonen, J; Neuvonen, PJ; Olkkola, KT | 1 |
| Bardazzi, F; Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A; Venturo, N | 1 |
| Phillips, P | 1 |
| Karvonen, J; Ruutu, P | 1 |
| Baran, R; de Doncker, P | 1 |
| De Backer, M; De Keyser, P; De Vroey, C; Lesaffre, E | 1 |
| Odom, RB | 1 |
| Fernández-Redondo, V; Ginarte, M; Pereiro, M; Toribio, J | 1 |
| De Doncker, P; Dubois, DJ; Eggleston, A; Gupta, AK; Haneke, E; Tormans, G; Van Doorslaer, EK; Van Rossem, K | 1 |
| Suarez, S | 1 |
| Lorenzi, S; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
| De Doncker, P; Gupta, AK; Sauder, DN; Scher, RK; Shear, NH | 1 |
| Boukhabza, A; Faergemann, J; Jones, TC; Smith, SG; Zehender, H | 1 |
| Cox, NJ; Meis, JF; Verweij, PE | 1 |
| Hull, PR | 1 |
| Richardson, MD | 1 |
| Arndt, KA; Dover, JS | 1 |
| Barchiesi, F; Falconi Di Francesco, L; Scalise, G | 1 |
| Epstein, E | 2 |
| Piérard, GE | 1 |
| Del Rosso, JQ | 1 |
| Hecker, D | 1 |
| Haustein, UF; Nenoff, P | 1 |
| Joseph, WS | 2 |
| Cerri, A; Crosti, C; Gianni, C | 2 |
| Arzeni, D; Barchiesi, F; Compagnucci, P; Di Francesco, LF; Giacometti, A; Scalise, G | 1 |
| Baran, E; Decroix, J; Del Palacio, A; Gwiezdzinski, Z; Levy, G; Tausch, I; Urbanowski, S; Ziarkiewicz, M | 1 |
| Friedlander, SF; Suarez, S | 2 |
| Evans, EG | 2 |
| Hazen, KC | 1 |
| Leyden, J | 1 |
| Katz, HI | 2 |
| Bräutigam, M | 1 |
| De Backer, M; De Keyser, P; De Vroey, C; Lesaffre, E; Scheys, I | 1 |
| Bootman, JL | 1 |
| Seebacher, C | 3 |
| Amichai, B; Grunwald, MH | 1 |
| Elewski, BE | 2 |
| Bruynzeel, I; Starink, TM | 1 |
| Jimenez, T; López-Jodra, O; Madrenys-Brunet, N; Siddat, M; Torres-Rodríguez, JM | 1 |
| Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
| Bräutigam, M; Nolting, S; Weidinger, G | 1 |
| McGinnis, MR; Pasarell, L | 1 |
| English, BK; Frisch, G; Kaufman, L; Kaufman, RA; Pearson, TA; Rinaldi, MG; Shenep, JL; Thompson, JW | 1 |
| Baudraz-Rosselet, F; Mock, M; Monod, M; Panizzon, RG | 1 |
| Haroon, TS; Hussain, I; Jahangir, M; Ul Hasan, M | 1 |
| Difonzo, EM; Miracco, C; Romano, C | 1 |
| Friedlander, SF | 1 |
| Korting, HC | 1 |
| Frieden, IJ; Howard, RM | 1 |
| Angello, JT; Jan, SA; Voytovich, RM | 1 |
| Gupta, AK | 3 |
| Evans, EG; Sigurgeirsson, B | 1 |
| Ellis, MR; Kane, KY | 1 |
| Kane, MP; Tom, CM | 1 |
| Degreef, H; del Palacio, A; Ginter, G; Mygind, S; Pinto Soares, A; Zuluaga de Cadena, A | 1 |
| Nishimoto, K | 1 |
| Gupta, AK; Katz, HI; Shear, NH | 1 |
| Church, L; Warrick, D | 1 |
| De Doncker, P; Gupta, AK | 1 |
| Kejda, J | 1 |
| Aly, R; Cel Rosso, JQ; Daniel, CR; De Doncker, P; Elewski, BE; Gupta, AK; Jacko, M; Marynissen, G; Meuleneers, L; Moskovitz, B; Odom, RB; Rosen, T; Scher, RK; Shear, N; Verspeelt, J | 1 |
| Albreski, DA; Gross, EG; Gupta, AK | 1 |
| De Rosso, JQ; Gupta, AK | 1 |
| Del Rosso, JQ; Gupta, AK | 2 |
| De Doncker, P | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 2 |
| Gupta, AK; Lambert, J | 1 |
| Gupta, AK; Shear, NH | 1 |
| Gee, SL; Mehregan, DR | 1 |
| Meis, JF; Meletiadis, J; Mouton, JW; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Jain, S; Sehgal, VN | 2 |
| Korting, HC; Niewerth, M | 1 |
| Billstein, S; di Fonzo, E; Evans, EG; Goodfield, MJ; Rantanen, T; Ruzicka, T; Sigurgeirsson, B; Vermeer, BJ | 1 |
| De Cuyper, C; Hindryckx, PH | 1 |
| McGinnis, MR; Nordoff, NG; Nunn, GB; Ryder, NS | 1 |
| Burkhart, CG | 1 |
| Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
| Glick, B; Rebell, G; Zaiac, MN; Zaias, N | 1 |
| De Doncker, P; Degreef, H; Gupta, AK | 1 |
| Gupta, AK; Summerbell, RC | 1 |
| Assaf, C; Goerdt, S; Orfanos, C; Seibold, M | 1 |
| Khosravi, AR; Mansouri, P; Moazzeni, M | 1 |
| Rand, S | 1 |
| Smith, EB | 1 |
| Drake, L; Gupta, AK; Lambert, J; Shear, N; Yaniv, R | 1 |
| Takasuka, T | 1 |
| Gupta, AK; Konnikov, N; Lynde, CW | 2 |
| Zakai, HA; Zimmo, SK | 1 |
| Bassler, M; Rodgers, P | 1 |
| Chambliss, ML; DeSpain, J; Johnston, KL | 1 |
| Leitner, I; Ryder, NS | 1 |
| Abeck, D; Möhrenschlager, M | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Agaoglu, C; Alpay, K; Bahadir, S; Cimsit, G; Inalöz, HS; Parlat, P | 1 |
| Denning, DW; Moore, CB; Walls, CM | 1 |
| Jansen, R; Redekop, WK; Rutten, FF | 1 |
| Gregurek-Novak, T; Gupta, AK | 1 |
| Clyti, E; Couppie, P; Heid, E; Pradinaud, R; Sainte Marie, D | 1 |
| Hamaguchi, T; Morishita, N; Ninomiya, J; Sei, Y; Takiuchi, I; Yamazaki, K | 1 |
| Chen, BK; Friedlander, SF | 1 |
| Adamski, Z; Dworacki, G; Maleszka, R | 1 |
| Billstein, S; Evans, EG; Olafsson, JH; Paul, C; Sigurgeirsson, B; Steinsson, JB | 1 |
| Heikkilä, H; Stubb, S | 1 |
| Fernández-Torres, B; Guarro, J; Pereiro, M | 1 |
| Guarnieri, L; Mancianti, F; Millanta, F; Pedonese, F | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Akar, A; Arca, E; Gür, AR; Kurumlu, Z; Taştan, HB | 1 |
| Dannaoui, E; Meis, JF; Mouton, JW; Verweij, PE | 1 |
| Fukuda, T | 2 |
| Bell-Syer, SE; Brunt, E; Crawford, F; Godfrey, C; Hart, R; Russell, I; Young, P | 1 |
| Colombo, MD; Ghetti, E; Piraccini, BM; Tosti, A | 1 |
| Boissel, JP; Cribier, BJ; Haugh, M; Helou, S | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Glad'ko, VV; Tarasenko, GN | 1 |
| Batista, RD; Fontes, CJ; Hahn, RC; Hamdan, JS | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Edlind, TD; Smith, WL | 1 |
| Abarca, L; Cabañes, FJ; Carrillo-Muñoz, AJ; Esteban, A; Fernández-Torres, B; Guarro, J; Inza, I | 1 |
| Cuenca-Estrella, M; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP | 1 |
| Gupta, AK; Sanzovo, AD; Taborda, PR | 1 |
| Darkes, MJ; Goa, KL; Scott, LJ | 1 |
| Baran, R; Gupta, AK; Summerbell, R | 1 |
| Kantarcioğlu, AS; Yucel, A | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Child, FJ; Fuller, LC; Higgins, EM; Midgley, G | 1 |
| Botek, G | 1 |
| Boyle, J; Roberts, DT; Taylor, WD | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Amaya, K; Arikian, S; Casciano, J; Doyle, J; Haspel, M; Kahler, K; Shear, N | 1 |
| Fouad, MA; Zakai, HA; Zimmo, SKh | 1 |
| De Maubeuge, J; Kolivras, A; Lateur, N; Scheers, C; Song, M; Wiame, L | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Grooters, AM; Taboada, J | 1 |
| Gupta, AK; Kohli, Y | 1 |
| Gupta, AK; Ryder, JE | 1 |
| De Hoog, GS; Verweij, PE; Vitale, RG | 1 |
| Böni, R | 1 |
| Akula, I; Edlind, T; Jain, P | 1 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Arikan, S; Cetin, ES; Karaarslan, A; Karaarslan, F | 1 |
| Biton, A; Chetov, T; Cohen, AD; Medvesovsky, E; Naimer, S; Shai, A; Shalev, R; Vardy, DA | 1 |
| Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB | 1 |
| Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
| Araki, Y; Higuchi, R; Mochizuki, T; Takahashi, C; Takiuchi, I | 1 |
| Reinel, D | 1 |
| Chan, YC; Friedlander, SF | 1 |
| Gupta, AK; Johnson, AM; Ryder, JE | 1 |
| Moriello, KA | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Armstrong, D; Bondar, G; Werschler, WP | 1 |
| Andrade, TS; Castro, LG; Cury, AE; Gimenes, VM; Nunes, RS | 1 |
| Arikan, S; Karaarslan, A; Ozcan, KM; Ozcan, M | 1 |
| Hahn, RC; Hamdan, JS; Kohler, LM; Monteiro, PC | 1 |
| Lagana, FJ | 1 |
| Ratajczak-Stefańska, V | 1 |
| Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V | 1 |
| Abarca, ML; Cabañes, FJ; Esteban, A | 1 |
| Ausma, J; Backx, LJ; Borgers, M; Corens, D; De Groot, A; Heeres, J; Marichal, PJ; Meerpoel, L; Odds, FC; Oris, M; Van Breda, A; Van der Veken, LJ; van Dorsselaer, P; Van Gerven, F; Vanden Bossche, HF; Vermuyten, KJ; Willemsens, GH; Woestenborghs, FA | 1 |
| Friedlander, SF; Roberts, BJ | 1 |
| Batra, R; Gupta, AK; Kohli, Y | 1 |
| de Almeida, HL; Defferrari, R; Duquia, RP; Prochnau, A; Souza, PR; Vetoratto, G | 1 |
| Ayangil, D; Cankaya, S; Ferahbaş, A; Koc, AN; Silici, S | 1 |
| Afonso, E; Candido, RC; Ferreira, JC; Krakhecke, AG | 1 |
| Brown, M; Pasvol, G | 1 |
| Carver, SM; Fett, DD; Lederle, FA; Nelson, D; Warshaw, EM; Webster, N; Zielke, GR | 1 |
| Alvarado, P; de Albornoz, MC; Díaz de Torres, E; Lucena, L; Mendoza, M | 1 |
| Arikan, S; Ayhan, M; Karaduman, A; Sancak, B | 1 |
| Chowdhury, AH; Hoque, MM; Khan, RM; Mamun, SA; Sikder, AU | 1 |
| Crawford, F; Ferrari, J | 2 |
| Dai, XY; Hu, Y; Hua, HK; Qi, J; Sun, H; Wei, L; Yang, LJ; Zheng, Y | 1 |
| Hiruma, M | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Choczaj-Kukuła, A; Kwaśniewska, J | 1 |
| Tietz, HJ | 1 |
| Macura, AB; Pawlik, B; Szczepko, I | 1 |
| Almeida, SR; Criado, PR; Gimenes, VM; Martins, JE | 1 |
| Nikkels, AF; Nikkels-Tassoudji, N; Piérard, GE | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Alvarez, MS; Silverberg, NB | 1 |
| Gover, MD; Gupta, AK; Lynde, CW | 1 |
| Barros, ME; Hamdan, JS; Santos, Dde A | 1 |
| Da Silva Barros, ME; de Assis Santos, D; Hamdan, JS; Kohler, LM; Soares, BM | 1 |
| Abeck, D; Brasch, J; Cornely, O; Daeschlein, G; Effendy, I; Ginter-Hanselmayer, G; Haake, N; Hamm, G; Hipler, UC; Hof, H; Korting, HC; Kramer, A; Mayser, P; Ruhnke, M; Schlacke, KH; Seebacher, C; Tietz, HJ | 1 |
| Barros, MEDS; Hamdan, JS; Santos, DA | 1 |
| Bonifaz, A; Fierro, L; Paredes, V | 1 |
| Chen, S; Li, J; Li, S; Liu, Z; Tu, Y; Wu, Y | 1 |
| Neoh, CY; Perera, P; Tan, SH | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Korting, HC; Schmid-Wendtner, MH | 1 |
| Can, F; Demirbilek, M; Sarifakioglu, E; Seçkin, D | 1 |
| Chan, AK; Chang, CH; Kurth, T; Orav, JE; Young-Xu, Y | 1 |
| Ali, S; Forgie, SE; Graham, TA | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Bergus, G; González, U; Jacobson, J; Martínez-Monzón, C; Seaton, T | 1 |
| Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W | 1 |
| Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A | 1 |
| Ginter-Hanselmayer, G; Smolle, J; Weger, W | 1 |
| Hiruma, M; Muto, M; Sugita, T; Takahata, Y | 1 |
| Abe, M; Abe, S; Ikeda, R; Maeasaki, S; Mohri, S; Nishiyama, Y; Oguri, T; Shibuya, K; Toshio, K; Uno, J; Watanabe, S | 1 |
| Hiruma, M; Ikeda, S; Shiraki, Y; Sugita, T | 1 |
| Hiromoto, A; Nagano, T; Nishigori, C | 1 |
| Cárdenes, D; Carrillo-Muñoz, AJ; del Valle, O; Eraso, E; Giusiano, G; Guardia, C; Guarro, J; Hernández-Molina, JM; Quindós, G; Tur-Tur, C | 1 |
| Li, R; Liu, L; Wan, Z; Yu, J; Zhang, M | 1 |
| De Hoog, S; Li, X; Lu, C; Xi, L; Xie, T; Xie, Z; Zhang, H; Zhang, J | 1 |
| Li, L; Li, R; Luo, S; Sun, X; Wang, Z | 1 |
| Brown, TA; Grooters, AM; Hosgood, GL | 1 |
| Bächli, EB; Ebnöther, C; Fischer, N; Ruef, Ch | 1 |
| Abreu, S; Cambuim, I; de Queiroz, LA; Gomes, BS; Maia, R; Porto, AL; Siqueira, AB; Souza-Motta, CM | 1 |
| Barber, J; Barber, K | 1 |
| Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
| Geng, S; Hiruma, M; Ikeda, S; Li, Y; Liu, H; Lu, X; Ogawa, H; Sugita, T; Wang, Y; Yang, Q; Yang, X; Zhou, X | 1 |
| de Berker, D | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Li, R; Liu, W; Wan, Z; Wang, X; Yang, J | 1 |
| Ameen, M | 1 |
| Hiruma, M; Kunitake, Y; Noguchi, H | 1 |
| Yap, FB | 2 |
| Brown, SJ | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Hiruma, M; Ogawa, Y | 1 |
| Kusuhara, M | 1 |
| Barabino, G; Machetti, M; Perotti, M; Persi, A; Zotti, M | 1 |
| Altas, K; Iscimen, A; Kaner, G; Kantarcioglu, AS; Sarikaya, E; Summerbell, RC; Sutton, DA; Yücell, A | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Piraccini, BM; Sisti, A; Tosti, A | 1 |
| Daniel, CR; Jellinek, NJ | 1 |
| Anzawa, K; Hatta, J; Hatta, T; Hirota, T; Kitahara, Y; Miyagawa, S; Mochizuki, T | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Das, S; Goyal, A; Gupta, N; Jain, S | 1 |
| Angelini, P; Granetti, B; Pagiotti, R; Rubini, A; Tirillini, B; Venanzoni, R | 1 |
| Cos, P; de Wit, K; Maes, L; Matheeussen, A; Paulussen, C; van Rossem, K | 1 |
| Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH | 1 |
| Ishikawa, T; Kanda, N; Kano, R; Watanabe, S | 1 |
| Alvarez, E; Cano, JF; Dromer, F; Fothergill, AW; Garcia-Hermoso, D; Guarro, J; Hoinard, D; Rinaldi, MG; Stchigel, AM; Sutton, DA | 1 |
| Hattori, M; Hiruma, M; Noguchi, H; Sakae, H | 1 |
| Maeda, M; Nomura, M; Seishima, M | 1 |
| Curi, AL; de Almeida Paes, R; de Lima Barros, MB; Francesconi do Valle, AC; Francesconi, G; Galhardo, MC; Liporage, J; Passos, SL; Porto, CF | 1 |
| Birkenheuer, A; Davidson, G; Grooters, A; Hummel, J; Jennings, S; Nicklas, J | 1 |
| Fahal, AH; van Belkum, A; van de Sande, WW | 1 |
| Arslan, U; Fındık, D; Solgun, G; Türk Dağı, H | 1 |
| Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
| Li, SS; Liu, YY; Song, Y; Tian, YP; Yao, L; Zhong, SX | 1 |
| Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
| Boada, A; Carrascosa, JM; Ferrándiz, C; Fuente, MJ; Morell, L | 1 |
| Biancalana, FS; Lyra, L; Schreiber, AZ | 1 |
| Abliz, P; Cheng, W; Deng, S; Hu, H; Li, R; Wan, Z; Wang, A | 1 |
| Harada, T | 1 |
| Joseph, NM; Pradeepkumar, NS | 1 |
| Luo, D; Xu, J; Yin, Z | 1 |
| Byekova, Y; Elewski, B; Hughey, L | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Bacon, NJ; Flynn-Lurie, A; Grooters, AM; Kirkby, KA; Thieman, KM | 1 |
| Fan, YM; Huang, WM; Li, W; Lin, YP; Yang, YP | 1 |
| Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Maboni, G; Pereira, DI; Pereira, PL; Pötter, L; Sallis, ES; Santurio, JM; Silveira, F; Zanette, RA | 1 |
| Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J | 1 |
| Bergman, R; Izhak, OB; Mayer, E | 1 |
| Hasegawa, A; Itoi, S; Kamata, H; Kano, R | 1 |
| Alexis, A; Bhanusali, D; Coley, M; Silverberg, JI; Silverberg, NB | 1 |
| Bell, D; Cornell, KK; Epstein, J; Schmiedt, CW; Stratton-Phelps, M; Torres, BT; Uhl, EW; Zimmerman, S | 1 |
| Guerra, CR; Ishida, K; Nucci, M; Rozental, S | 1 |
| Cornish, NE; Rangamani, S; Van Schooneveld, TC; Varman, M | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Ananiev, J; Cardoso, JC; Ginter-Hanselmayer, G; Guarneri, C; Gulubova, M; Hristova, R; Kanazawa, N; Martino, G; Nenoff, P; Nocheva, D; Penev, PK; Taneva, T; Tchernev, G; Zisova, LG | 1 |
| Galgóczy, L; Papp, T; Tóth, L; Vágvölgyi, CS; Virágh, M | 1 |
| Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y | 1 |
| Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y | 1 |
| Chen, L; Chen, SC; Dong, B; Duan, Y; Hu, Z; Jiang, P; Li, D; Li, R; Tong, Z | 1 |
| Helou, J; Maatouk, I; Moutran, R; Obeid, G | 1 |
| Benchikhi, H; Hali, F; Khadir, K; Marouane, S; Ouakadi, A; Radouane, N; Soussi, M; Zamiati, S | 1 |
| Li, R; Yu, J; Zhang, S | 1 |
| Cai, Q; Hu, SQ; Jiang, YQ; Liu, WD; Lv, GX; Mei, H; Shen, YN; Wu, XF; Xu, HB | 1 |
| Baudraz-Rosselet, F; Lurati, M; Monod, M | 1 |
| Cardoso, FJ; Chaves, GM; Colalto, W; Melo, AS; Silva-Rocha, WP | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Fonseca, AO; Jesus, FP; Lobo, RR; Motta, MA; Pereira, DI; Santurio, JM; Soares, MP | 1 |
| Bulut, Y; Tunçoğlu, E; Yenişehirli, A; Yenişehirli, G | 1 |
| Hata, Y | 1 |
| de Sá, DC; Lamas, AP; Tosti, A | 1 |
| Grooters, A; Knorr, J; Oldenhoff, W; Pinkerton, ME; Trepanier, L | 1 |
| Baudraz-Rosselet, F; Bontems, O; Monod, M; Verrier, J | 1 |
| Bulgheroni, A; Celandroni, F; Ghelardi, E; Gueye, SA; Mailland, F; Salvetti, S; Senesi, S | 1 |
| Abhinav, C; Chauhan, PS; Mahajan, VK; Mehta, KS; Prabha, N; Rudramurthy, SM; Sharma, NL; Sharma, V; Thakur, K | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Hamblin, MR; Hu, Y; Huang, X; Lu, S; Mylonakis, E; Xi, L; Zhang, J | 1 |
| Ahmed, SA; de Hoog, GS; Fahal, AH; Kloezen, W; van de Sande, WW | 1 |
| Backman, JT; Hagelberg, NM; Laine, K; Neuvonen, PJ; Olkkola, KT; Saari, TI; Saarikoski, T; Scheinin, M | 1 |
| Liu, W; Lv, G; Ping, Z; She, X; Shen, Y; Wang, C; Wang, L; Zeng, R | 1 |
| Fahal, AH; Nenoff, P; Reinel, D; Schöfer, H; van de Sande, WW | 1 |
| Ikeda, F; Iyoda, T; Mikawa, T; Suzuki, M; Yamaguchi, H | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Fan, YM; Huang, WM; Li, W; Sheng, P; Yang, YP; Zhu, CY | 1 |
| Arzeni, D; Barchiesi, F; Castelli, P; Cirioni, O; Conte, I; Giacometti, A; Kamysz, E; Kamysz, W; Morciano, A; Offidani, AM; Orsetti, E; Scalise, A; Silvestri, C; Simonetti, O; Staffolani, S | 1 |
| Gunasekara, TA; Nagahawatte, A; Ranawaka, RR | 1 |
| Pajaziti, L; Vasili, E | 1 |
| Kampirapap, K; Ornpaew, P; Reangchainam, S; Tresukosol, P | 1 |
| de Silva, SH; Gunasekara, TA; Nagahawatte, A; Ranawaka, RR; Weerakoon, HS | 1 |
| Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Chanda, S; Coronado, D; Del Rosso, J; Zane, LT | 1 |
| Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M | 1 |
| Arendrup, MC; Digby, SS; Hald, M; Hjort, SV; Kofoed, K | 1 |
| Chen, R; Chen, Y; de Hoog, GS; Deng, S; Feng, P; Lai, W; Li, M; Lu, C; Ma, H; Wei, L; Yin, S | 1 |
| García-Romero, MT; Solís-Arias, MP | 1 |
| Bexton, S; Nelson, H | 1 |
| Han, X; Hu, Y; Huang, S; Liu, K; Lu, Y; Mao, Z; Wu, Z; Zhou, X | 1 |
| Balta, I; Oz, A; Oz, Y; Qoraan, I | 1 |
| de Silva, SH; Ranawaka, RR | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Feng, X; Ran, Y; Xiong, X | 1 |
| Chen, C; Han, HS; Kano, R; Noli, C | 1 |
| Eadie, K; Fahal, A; Helvert-van Poppel, M; Parel, F; van de Sande, W | 1 |
| Almeida-Paes, R; Brito-Santos, F; Figueiredo-Carvalho, MHG; Gutierrez-Galhardo, MC; Machado, ACS; Oliveira, MME; Pereira, SA; Zancopé-Oliveira, RM | 1 |
| Brandolt, TM; Klafke, GB; Poester, VR; Sanchotene, KO; Xavier, MO | 1 |
| Cox, SK; Redig, P; Souza, MJ | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Agarwal, R; Agarwal, S; Gupta, S; Gupta, V; Sahoo, AK; Singh, G; Xess, I | 1 |
| Albrecht-Eckardt, D; Amarsaikhan, N; Braus, GH; Kniemeyer, O; Ogel, ZB; Sasse, C | 1 |
| Brakhage, AA; Kniemeyer, O; Shekhova, E | 1 |
| Siew, HH | 1 |
| Babaev, M; Daniel, CR; Farhi, R; Foley, KA; Gupta, AK; Kamshov, A; Shemer, A | 1 |
| Chang, WL; Chiu, HY; Shiu, MN; Tsai, TF; Tsai, YW | 1 |
| He, L; Li, X; Lu, S; Ma, J; Mei, X; Xi, L | 1 |
| Andersen, LK; Arendrup, MC; Schøsler, L; Sommerlund, M | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Chindamporn, A; Chitasombat, MN; Krajaejun, T; Larbcharoensub, N | 1 |
| Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG | 1 |
| Lipner, SR; Scher, RK | 1 |
| Arenas, R; Castillo, A; Espinoza-Rivera, M; Hernández-Castro, R; Romero-Navarrete, M; Ruíz, LF; Vega-Memije, ME; Xicohtencatl-Cortes, J | 1 |
| He, Y; Tan, J; Yang, L; Zhang, J | 1 |
| Bate, A; Hurley, S; Liu, Q; Petronis, KR; Schachterle, SE | 1 |
| Fukutomi, T; Kamata, H; Kano, R; Oshimo, K | 1 |
| Chan, JFW; Chan, KF; Cheung, M; Fung, KSC; Lai, CKC; Lau, ECL; Lau, SKP; Lee, CY; Li, X; Ng, RHY; Ngan, AHY; Tang, JYM; Tsang, CC; Woo, PCY | 1 |
| Della Maggiore, A; Grooters, AM; Marks, SL; Pesavento, PA; Reagan, KL; Zhu, BY | 1 |
| Alastruey-Izquierdo, A; de Hoog, S; Kurzai, O; Voigt, K; Wagner, L; Walther, G | 1 |
| Babaev, M; Daniel, CR; Farhi, R; Foley, KA; Gupta, AK; Hermush, V; Kamshov, S; Shemer, A | 1 |
| Guo, K; Wang, S; Wang, Z; Zhang, L | 1 |
| Afsarian, MH; Ahmadi, B; Ansari, S; Ansari, Z; Lotfali, E; Norouzi, M; Rezaei-Matehkolaei, A | 1 |
| Khurana, A; Sardana, K; Singh, A | 1 |
| Bhalla, M; Sharma, P; Thami, GP | 1 |
| Bang, YJ; Jun, JB; Lee, EH; Lee, WJ | 1 |
| Chen, X; Hu, Y; Liu, K; Lu, Y; Mao, Z; Qi, X; Sun, H; Wu, Z; Yang, Y; Zhou, X | 1 |
| Bamimore, MA; Foley, KA; Gupta, AK; Piguet, V; Shear, NH; Stec, N | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Amin, K; Cartwright, D; Gaertner, W; Plummer, R; Wheelwright, M; Yousaf, H | 1 |
| Cui, Y; Li, SS; Song, Y; Yao, L; Zhou, JF | 1 |
| Chindamporn, A; Permpalung, N; Worasilchai, N | 1 |
| Harada, K; Hase, M; Hiruma, J; Hiruma, M; Kamata, H; Kano, R; Noguchi, H; Yokota, M | 1 |
| Demitsu, T; Harada, K; Hiruma, J; Kakurai, M; Kano, R; Maeda, T | 1 |
| Chindamporn, A; Chuleerarux, N; Manothummetha, K; Permpalung, N; Plongla, R; Torvorapanit, P; Worasilchai, N | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Gupta, AK; Piguet, V; Piraccini, BM; Shear, NH; Stec, N; Summerbell, RC; Tosti, A | 1 |
| Abd Elhameed, MI; Abu El-Hamd, M; Saleh, R; Shalaby, MFM | 1 |
| Anchan, VN; Chandra, U; Singh, S; Tilak, R; Verma, P | 1 |
| Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
| Almeida-Paes, R; Boechat, JS; de Oliveira, MME; de Sá Machado, AC; Gremião, IDF; Pereira, SA; Viana, PG; Zancopé-Oliveira, RM | 1 |
| El-Hawary, EE; Fawzy, MM; Nofal, A | 1 |
| Elewski, B | 1 |
| Mukherjee, K; Ray, A; Ray, DS; Sarkar, A; Thukral, S | 1 |
| Mathachan, SR; Sardana, K | 1 |
| Lan, Y; Lu, S; Zhang, J | 1 |
| Andrianarison, M; Cornet, M; Maubon, D; Raharolahy, O; Rakoto Andrianarivelo, M; Rakotoarisaona, MF; Ramarozatovo, LS; Ranaivo, IM; Rapelanoro Rabenja, F; Rasamoelina, T; Ratovonjanahary, V; Razanakoto, NH; Sata, M; Sendrasoa, FA | 1 |
| Cridge, H; Hughes, SM; Langston, VC; Mackin, AJ | 1 |
| Cai, W; Chen, Z; He, Y; Lan, Y; Li, Y; Xi, L; Xiao, X; Zhang, J | 1 |
| Geizhals, S; Lipner, SR | 1 |
| Cardenas-de la Garza, JA; Cuellar-Barboza, A; Escalante-Fuentes, W; Gallardo-Rocha, A; Molina-Torres, CA; Ocampo-Candiani, J; Vera-Cabrera, L | 1 |
| Denk, D; Guthrie, A; Macgregor, SK; Reed, K; Stidworthy, MF | 1 |
| Belda Junior, W; Criado, PR; da Matta, VLR | 1 |
| Gupta, AK; Quinlan, EM; Summerbell, RC; Venkataraman, M | 1 |
| Ranawaka, RR | 1 |
| Crespo-Szabo, SM; Stafford, JR | 1 |
| Aharaz, A; Hay, RJ; Jemec, GBE; Saunte, DML | 1 |
| Ahmad Nasrollahi, S; Fattahi, A; Firooz, A; Khamesipoor, A; Lotfali, E; Miramin Mohammadi, A; Naeimifar, A; Skandari, SE | 1 |
| Agarwal, A; Agrawal, D; Chowdhary, A; Ghadlinge, M; Khurana, A; Panesar, S; Sardana, K; Sethia, K; Singh, A | 1 |
| Bidaud, AL; Chowdhary, A; Dannaoui, E; Schwarz, P | 1 |
| Lipner, SR; Wang, Y | 1 |
| Chindamporn, A; Plongla, R; Suankratay, C; Thammahong, A; Thongsuk, P; Tiewsurin, J; Worasilchai, N | 1 |
| Guillot, J; Rezaei-Matehkolaei, A; Shamsizadeh, F; Shariat Nabavi, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Gupta, AK; Talukder, M; Venkataraman, M | 1 |
| Fukushima, S; Hiruma, M; Kano, R; Kashiwada-Nakamura, K; Kimura, U; Kubo, M; Matsumoto, T; Noguchi, H; Yaguchi, T | 1 |
| Hiruma, M; Kano, R; Noguchi, H | 1 |
| Do, TBT; Ha, TNT; Le, CC; Ngo, TMC; Nguyen, PV; Santona, A; Ton Nu, PA; Tran Thi, G; Vo, MT | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Jowkar, F; Kharazi, M; Khodadadi, H; Mohammadi, T; Motamedi, M; Nasr, R; Nouripour-Sisakht, S; Rezaei-Matehkolaei, A; Sasanipoor, F; Yazdanpanah, S; Zomorodian, K | 1 |
| Agarwal, A; Agrawal, D; Chowdhary, A; Khurana, A; Sardana, K; Singh, A | 1 |
| Cooper, EA; Gupta, AK; Hall, DC; Summerbell, RC; Venkataraman, M | 1 |
| Bonfietti, L; de Camargo, ZP; de Carvalho, JA; de Souza Carvalho Melhem, M; de Souza Lima, BJF; Guevara, A; Hagen, F; Hahn, RC; Nery, AF; Rodrigues, AM; Vicente, VA | 1 |
| Fatima, SH; Ismail, BA; Minhajuddin, A; Nawab, M; Rasheed Naikodi, MA | 1 |
| Al-Badriyeh, D; Chan, EW; Cowling, BJ; Hung, IFN; Kong, DCM; Neoh, CF; Pathadka, S; Slavin, MA; Wong, ICK; Yan, VKC | 1 |
| Almeida-Paes, R; Almeida-Silva, F; Alves, GM; Amaral, ACF; Brito-Santos, F; Coelho, RA; de Souza, GR; Figueiredo-Carvalho, MHG; Lourenço, MCDS | 1 |
| Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX | 1 |
| Lin, L; Ma, J; Pan, Q; Tang, Z; Wu, Y; Zhang, J | 1 |
| Aguiar, ALR; da Silva, BN; de Aguiar Cordeiro, R; de Andrade, ARC; de Lima-Neto, RG; Lima, XTV; Maia, DCSC; Moura, SGB; Pereira, LMG; Portela, FVM; Reis, AT; Rocha, MFG; Sidrim, JJC | 1 |
| Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
| Benedict, K; Dulski, TM; Gold, JAW; Lipner, SR | 1 |
| Hirasawa, Y; Hiruma, M; Ikeda, S; Kano, R; Komiyama, E; Ogawa, T; Ogawa, Y; Tsuchihashi, H; Watanabe, M | 1 |
| Bhattacharyya, A; Ghosh, S; Gupta, S; Khurana, A; Sachdeva, S; Sadhasivam, S; Saini, S; Sardana, K; Singh, H; Sinha, M | 1 |
| Harada, K; Hiruma, J; Hiruma, M; Kano, R; Noguchi, H; Shimizu, T | 1 |
| Cai, W; Fang, J; Huang, J; Li, J; Lin, L; Lu, S; Zhang, J | 1 |
| Abusamra, L; Cañataro, PA; Daneri, AGL; Farbman, MA; Mujica, MT; Rodriguez, CHV | 1 |
| Bamimore, MA; Gupta, AK; Venkataraman, M | 1 |
| de Hoog, S; Kong, X; Li, X; Liang, G; Liu, W; Mei, H; She, X; Song, G; Tang, C; Zheng, H | 1 |
| Cañete-Gibas, CF; David, M; Fan, H; Ferrer, D; Garcia, V; Mele, J; Patterson, HP; Sanders, CJ; Wiederhold, NP | 1 |
| Konings, M; Ma, J; van de Sande, WWJ; Verbon, A | 1 |
| Bakotic, WL; Cooper, EA; Foreman, HC; Gupta, AK; Lincoln, SA; Polla Ravi, S; Wang, T | 1 |
| Cai, W; Li, J; Li, X; Lin, L; Lu, S; Ma, J; Xi, L; Zheng, B; Zhu, X | 1 |
| Rana, D; Rao, BK; Saleem, MA; Shah, RR; Sharif, S; Waqas, N | 1 |
| Burmester, A; Ebert, A; Monod, M; Nenoff, P; Schaller, M; Stahl, M; Uhrlaß, S | 1 |
| Eldahshan, RM; Elsaie, ML; Hassaan, ZRAA; Mohamed, HAK | 1 |
| Harada, K; Hiruma, J; Hiruma, M; Kano, R; Makimura, K; Noguchi, H; Nojo, H | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ji, H; Jiang, Q; Lü, J; Miao, Z; Sheng, C; Song, Y; Xu, H; Yao, J; Zhang, M; Zhang, W; Zhou, Y; Zhu, J | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Chen, SC; Guse, Z; Halliday, C; Jolliffe, KA; Kong, F; Lee, OC; Sorrell, TC; Tong, Z; Widmer, F; Wright, LC | 1 |
| Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
| Agudelo-Goméz, L; Betancur-Galvis, L; González, MA; Mancebo-Aracil, J; Mesa-Arango, A; Tangarife-Castaño, V; Zapata, B | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Breaker, RR; Li, S | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Aytemir, MD; Karakaya, G; Ozçelik, B | 1 |
| Betancur-Galvis, L; Castro, MÁ; Gamito, AM; Mesa-Arango, AC; Miguel del Corral, JM; San Feliciano, A; Tangarife-Castaño, V; Zapata, B | 1 |
| Chai, X; Hu, H; Huang, T; Li, R; Li, X; Wu, M; Wu, Q; Yu, S; Zhao, Q; Zou, Y | 1 |
| Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beuerman, RW; Cao, D; Koh, JJ; Lim, F; Lin, S; Liu, S; Ren, L; Sin, WLW; Wang, L | 1 |
| Han, H; Qi, XR; Shen, L; Tang, HF; Xu, QZ; Yang, WS; Yi, YH; Yuan, CH | 1 |
132 review(s) available for itraconazole and terbinafine
| Article | Year |
|---|---|
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Models, Econometric; Naphthalenes; Onychomycosis; State Medicine; Terbinafine | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
New approaches to the treatment of onychomycosis.
Topics: Adult; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[New antifungal agents in the treatment of superficial dermatomycoses].
Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate | 1993 |
[Oral antifungal drugs].
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Management of scalp ringworm.
Topics: Antifungal Agents; Child; Child, Preschool; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tinea Capitis; United Kingdom | 1996 |
New antifungal therapy for children.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Fluconazole; Hair Diseases; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Onychomycosis--treatment, relapse and re-infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prognosis; Recurrence; Terbinafine | 1997 |
Current trends in onychomycosis therapy: a literature review.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Oral treatment options for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Antifungal therapy in children: an update.
Topics: Antifungal Agents; Child; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Arthrodermataceae; Candida; Drug Resistance, Microbial; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Pharmacokinetics and pharmacology of terbinafine and itraconazole.
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Ergosterol; Humans; Itraconazole; Metabolic Clearance Rate; Nails; Naphthalenes; Terbinafine | 1998 |
Systemic antifungal agents used to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Arthrodermataceae; Candida; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials.
Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Support Techniques; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
[Diagnosis, differential diagnosis and therapy of onychomycosis].
Topics: Administration, Topical; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Adverse drug reactions of the new oral antifungal agents--terbinafine, fluconazole, and itraconazole.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Pediatric antifungal therapy.
Topics: Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Terbinafine | 1998 |
How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Remission Induction; Terbinafine | 1998 |
The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 1999 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton | 1999 |
Management of toenail onychomycosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Toes | 1999 |
Oral therapy of common superficial fungal infections of the skin.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 1999 |
[Antifungal drugs for pediatric use].
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Naphthalenes; Terbinafine | 1999 |
Drug interactions with itraconazole, fluconazole, and terbinafine and their management.
Topics: Animals; Antifungal Agents; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Risk Assessment; Terbinafine | 1999 |
Itraconazole and terbinafine in perspective. From petri dish to patient.
Topics: Administration, Oral; Animals; Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Onychomycosis in diabetes. Management considerations.
Topics: Antifungal Agents; Diabetes Complications; Drug Interactions; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Management of onychomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; North America; Onychomycosis; Prevalence; Recurrence; Terbinafine | 1999 |
Management of tinea capitis. A status report.
Topics: Administration, Oral; Adult; Antifungal Agents; Carrier State; Child; Combined Modality Therapy; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 1999 |
Itraconazole and terbinafine in perspective: from petri dish to patient.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Foot Dermatoses; Humans; In Vitro Techniques; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Facing up to the diagnostic uncertainty and management of onychomycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Onychomycosis: treatment perspective.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Drug interactions of the newer oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Drug Interactions; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Naphthalenes; Terbinafine | 1999 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Tinea capitis.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Scalp; Terbinafine; Tinea Capitis | 2000 |
Overview: The treatment of dermatophytosis.
Topics: Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
The treatment of dermatophytosis: safety considerations.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Treating onychomycosis.
Topics: Adult; Antifungal Agents; Child; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Differential; Drug Costs; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Education as Topic; Recurrence; Teaching Materials; Terbinafine; Treatment Failure | 2001 |
Clinical inquiries. What is the best oral antifungal medication for tinea capitis?
Topics: Administration, Oral; Adult; Antifungal Agents; Child; Evidence-Based Medicine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2001 |
[A case of lymphocutaneous sporotrichosis].
Topics: Aged; Antifungal Agents; Humans; Itraconazole; Male; Naphthalenes; Potassium Iodide; Sporotrichosis; Terbinafine | 2001 |
Tinea capitis update: a continuing conflict with an old adversary.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Interactions; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; United States | 2001 |
A plea to bridge the gap between antifungals and the management of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
The future of onychomycosis therapy may involve a combination of approaches.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Combined Modality Therapy; Drug Therapy, Combination; Griseofulvin; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Patient Satisfaction; Prevalence; Quality of Life; Terbinafine; Treatment Failure | 2001 |
The rationale for combination therapy.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Cell Wall; Drug Therapy, Combination; Ergosterol; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 2001 |
Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Costs; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2002 |
Oral treatments for toenail onychomycosis: a systematic review.
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Terbinafine; Treatment Outcome | 2002 |
Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials.
Topics: Antifungal Agents; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine | 2002 |
[Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinocandins; Fluconazole; Fungi; Incidence; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Polyenes; Spain; Terbinafine | 2002 |
[Tinea capitis. Therapeutic options in the post-griseofulvin era].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome | 2002 |
Terbinafine: a review of its use in onychomycosis in adults.
Topics: Antifungal Agents; Arthrodermataceae; Diabetes Complications; Humans; Immunocompromised Host; Itraconazole; Mitosporic Fungi; Naphthalenes; Onychomycosis; Terbinafine; Yeasts | 2003 |
Onychomycosis: strategies to improve efficacy and reduce recurrence.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Biological Availability; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Diagnosis and management of scalp ringworm.
Topics: Administration, Oral; Antifungal Agents; Chemotherapy, Adjuvant; Griseofulvin; Humans; Itraconazole; Naphthalenes; Selenium Compounds; Terbinafine; Tinea Capitis | 2003 |
Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Topics: Adult; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Managed Care Programs; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2003 |
Itraconazole versus terbinafine in the management of onychomycosis: an overview.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
Update on antifungal therapy.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Cat Diseases; Cats; Dog Diseases; Dogs; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
New treatments for tinea capitis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2004 |
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 2004 |
Treatment of dermatophytosis in dogs and cats: review of published studies.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Calcium Compounds; Cat Diseases; Cats; Chlorhexidine; Clinical Trials as Topic; Dermatomycoses; Dog Diseases; Dogs; Griseofulvin; Imidazoles; Itraconazole; Miconazole; Naphthalenes; Sulfides; Terbinafine; Thiosulfates | 2004 |
Assessing treatment outcomes in toenail onychomycosis clinical trials.
Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome | 2004 |
Curing onychomycosis: understanding the multitude of variables.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The systemic treatment of onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The oral antifungal patient.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Selection; Recurrence; Terbinafine | 2004 |
Tinea capitis: a treatment update.
Topics: Antifungal Agents; Child; Dose-Response Relationship, Drug; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Pediatrics; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2005 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Risk Factors; Terbinafine | 2006 |
[Current possibilities of using antimyocotic drugs in the treatment of various skin disorders].
Topics: Animals; Antifungal Agents; Dermatitis, Atopic; Dermatitis, Seborrheic; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Skin Diseases; Terbinafine; Treatment Outcome | 2004 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Antifungal Agents; Clobetasol; Dermatomycoses; Humans; Inflammation; Itraconazole; Male; Middle Aged; Naphthalenes; Terbinafine; Trichophyton | 2006 |
Tinea capitis.
Topics: Antifungal Agents; Fluconazole; Global Health; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichosporon; United States | 2006 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine | 2007 |
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Liver Function Tests; Models, Statistical; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Risk Assessment; Terbinafine; Transaminases | 2007 |
The assessment and management of tinea capitis in children.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Fluconazole; Griseofulvin; Humans; Incidence; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2007 |
A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
Topics: Adult; Antifungal Agents; Aspergillus; DNA, Fungal; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Naphthalenes; Onychomycosis; Phylogeny; Pulse Therapy, Drug; Sequence Analysis, DNA; Terbinafine; Treatment Failure | 2008 |
Treatment of onychomycosis caused by dermatophytes--an opinion proposed by Committee for Standardization of the Japanese Society for Medical Mycology 2007.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Itraconazole; Japan; Mycology; Naphthalenes; Onychomycosis; Practice Guidelines as Topic; Societies, Medical; Terbinafine | 2008 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
Rhinofacial conidiobolomycosis caused by Conidiobolus coronatus in a Chinese rice farmer.
Topics: Adult; Agriculture; Antifungal Agents; Asian People; China; Conidiobolus; Culture Media; Drug Therapy, Combination; Face; Granuloma; Histocytochemistry; Humans; Hyphae; Itraconazole; Male; Mycology; Naphthalenes; Oryza; Paranasal Sinuses; Terbinafine; Zygomycosis | 2010 |
Clinical practice. Fungal nail disease.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Practice Guidelines as Topic; Pyridones; Terbinafine | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Chromoblastomycosis: clinical presentation and management.
Topics: Antifungal Agents; Chromoblastomycosis; Cryotherapy; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Species Specificity; Terbinafine; Tropical Climate | 2009 |
Efficacy of fluconazole for the treatment of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2009 |
[Dermatophytosis: a summary of dermatomycosis as a proposal for future revision of the guidelines].
Topics: Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Humans; Itraconazole; Naphthalenes; Practice Guidelines as Topic; Severity of Illness Index; Terbinafine | 2009 |
[Sporotrichosis and dematiaceous fungal skin infections].
Topics: Administration, Oral; Chromoblastomycosis; Combined Modality Therapy; Gastrointestinal Diseases; Humans; Itraconazole; Microscopy; Naphthalenes; Potassium Iodide; Sporothrix; Sporotrichosis; Terbinafine | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Basidiobolomycosis of the nose and face: a case report and a mini-review of unusual cases of basidiobolomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Entomophthorales; Face; Female; Head; Humans; India; Infant; Itraconazole; Male; Middle Aged; Naphthalenes; Nose; Terbinafine; Tomography, X-Ray Computed; Treatment Outcome; Zygomycosis | 2010 |
[Review of two Japanese cases with tinea faciei identified by molecular biological techniques as Arthroderma vanbreuseghemii].
Topics: Administration, Topical; Adult; Animals; Antifungal Agents; Arthrodermataceae; Asian People; Cats; Child; Dogs; Face; Female; Humans; Itraconazole; Male; Molecular Diagnostic Techniques; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Tinea; Treatment Outcome | 2010 |
[Tinea capitis].
Topics: Administration, Oral; Age Factors; Animals; Antifungal Agents; Female; Humans; Itraconazole; Japan; Male; Microsporum; Naphthalenes; Sex Factors; Terbinafine; Tinea Capitis; Trichophyton; Zoonoses | 2011 |
[Tinea unguium].
Topics: Aged; Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2011 |
A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Middle Aged; Naphthalenes; Onychomycosis; Recurrence; Terbinafine; Treatment Outcome | 2012 |
Systemic drugs in patients with skin diseases.
Topics: Cyclosporine; Fluconazole; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Itraconazole; Methotrexate; Mycophenolic Acid; Naphthalenes; Retinoids; Skin Diseases; Terbinafine | 2011 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Fluconazole; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Naphthalenes; Onychomycosis; Opportunistic Infections; Polymerase Chain Reaction; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Tinea | 2013 |
Generalized subcutaneous phaeohyphomycosis caused by Phialophora verrucosa: report of a case and review of literature.
Topics: Agriculture; Antifungal Agents; Asian People; DNA, Fungal; Histocytochemistry; Humans; Itraconazole; Lymphopenia; Male; Middle Aged; Molecular Sequence Data; Naphthalenes; Phaeohyphomycosis; Phialophora; Sequence Analysis, DNA; Terbinafine; Treatment Outcome | 2013 |
Canine gastrointestinal pythiosis treatment by combined antifungal and immunotherapy and review of published studies.
Topics: Animals; Antifungal Agents; Biopsy; Dog Diseases; Dogs; Drug Therapy, Combination; Duodenum; Gastrointestinal Diseases; Histocytochemistry; Immunologic Factors; Itraconazole; Microbiological Techniques; Naphthalenes; Pythiosis; Stomach; Terbinafine; Treatment Outcome | 2013 |
Oral therapy for onychomycosis: an evidence-based review.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2014 |
Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
Topics: Actinomycetales; Actinomycetales Infections; Amputation, Surgical; Animals; Anti-Bacterial Agents; Antifungal Agents; Cytokines; Debridement; Diagnosis, Differential; Humans; Inflammation; Itraconazole; Madurella; Mycetoma; Naphthalenes; Terbinafine; Triazoles | 2015 |
Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports.
Topics: Antifungal Agents; Ascomycota; Biopsy; Chromoblastomycosis; Cryotherapy; Dermatomycoses; Hand; Histocytochemistry; Humans; Immunosuppressive Agents; Itraconazole; Male; Microscopy; Middle Aged; Molecular Diagnostic Techniques; Molecular Sequence Data; Naphthalenes; Pemphigus; Sequence Analysis, DNA; Skin; Terbinafine; Treatment Outcome | 2015 |
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2016 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2016 |
Onychomycosis in children. A review.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Infant; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Humans; Itraconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
The Current Status of Feline Sporotrichosis in Malaysia.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malaysia; Naphthalenes; Prevalence; Sporothrix; Sporotrichosis; Terbinafine; Zoonoses | 2017 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton | 2018 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine; Treatment Outcome | 2020 |
Perianal Histoplasmosis Presenting as a Mass Suspicious for Malignancy: A Case Report with Review of Gastrointestinal Manifestations of Histoplasmosis.
Topics: Aged; Antifungal Agents; Anus Diseases; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Terbinafine | 2019 |
Human Pythiosis: Emergence of Fungal-Like Organism.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Glucans; Communicable Diseases, Emerging; Drug Combinations; Eye Infections, Fungal; Immunotherapy; Itraconazole; Oomycetes; Pathology, Molecular; Pythiosis; Pythium; Serologic Tests; Spores, Fungal; Terbinafine; Thalassemia; Vascular System Injuries | 2020 |
Onychomycosis: a review.
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine | 2020 |
Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review.
Topics: Aged; Aminolevulinic Acid; Antifungal Agents; Chromoblastomycosis; Humans; Isotretinoin; Itraconazole; Lasers; Lasers, Gas; Male; Photochemotherapy; Photosensitizing Agents; Retinoids; Terbinafine | 2021 |
A Timeline of Onychomycosis Therapy and Future Directions.
Topics: Administration, Topical; Antifungal Agents; Humans; Itraconazole; Nail Diseases; Onychomycosis; Terbinafine; Triazoles | 2020 |
Case Report: Coral Reef Pathogen Aspergillus sydowii Causing Black Grain Mycetoma.
Topics: Ankle; Antifungal Agents; Aspergillus; Female; Foot; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Terbinafine; Treatment Outcome | 2021 |
Nondermatophyte mould onychomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Onychomycosis; Onygenales; Terbinafine | 2021 |
Tinea capitis asymptomatic carriers: what is the evidence behind treatment?
Topics: Antifungal Agents; Child; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 2021 |
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
The emergence of Trichophyton indotineae: Implications for clinical practice.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study.
Topics: Adult; Antifungal Agents; Arthrodermataceae; Bayes Theorem; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Network Meta-Analysis; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management.
Topics: Antifungal Agents; Humans; Itraconazole; North America; Terbinafine; Tinea; Trichophyton | 2023 |
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review.
Topics: Antifungal Agents; Exophiala; Humans; Itraconazole; Male; Phaeohyphomycosis; Terbinafine | 2023 |
[Recurrent tinea corporis generalisata due to Terbinafine-resistant Trichophyton rubrum strain : Long-term treatment with super bioavailability itraconazole].
Topics: Aged, 80 and over; Biological Availability; Ciclopirox; Humans; Isoleucine; Itraconazole; Male; Squalene Monooxygenase; Terbinafine; Tinea | 2023 |
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
51 trial(s) available for itraconazole and terbinafine
| Article | Year |
|---|---|
Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1995 |
Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1995 |
A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Terbinafine; Tinea Pedis; Treatment Outcome | 1995 |
Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.
Topics: Adult; Antifungal Agents; Dermatomycoses; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Single-Blind Method; Terbinafine | 1995 |
Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study.
Topics: Administration, Oral; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Naphthalenes; Terbinafine; Tinea Pedis | 1994 |
A double-blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Indonesia; Itraconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea | 1994 |
Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.
Topics: Administration, Oral; Adult; Drug Interactions; Enzyme Inhibitors; Female; Humans; Itraconazole; Male; Midazolam; Naphthalenes; Terbinafine; Time Factors; Volunteers | 1995 |
Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
Topics: Administration, Oral; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Satisfaction; Terbinafine; Tinea Pedis | 1996 |
A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication.
Topics: Administration, Oral; Adult; Antifungal Agents; Double-Blind Method; Hair; Humans; Itraconazole; Male; Middle Aged; Nails; Naphthalenes; Sebum; Skin; Terbinafine | 1997 |
Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
Topics: Antifungal Agents; Double-Blind Method; Follow-Up Studies; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea; Tinea Pedis; Treatment Outcome | 1998 |
Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Trichophyton | 1998 |
Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Successful treatment of toenail mycosis with terbinafine and itraconazole gives long term benefits.
Topics: Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.
Topics: Antifungal Agents; Child; Child, Preschool; Double-Blind Method; Female; Humans; Itraconazole; Male; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 1998 |
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Dyspepsia; Female; Foot Dermatoses; Headache; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Nausea; Onychomycosis; Taste Disorders; Terbinafine; Treatment Outcome; Trichophyton; Virus Diseases | 1999 |
Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Topics: Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Long-term outcomes in the treatment of toenail onychomycosis.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Tinea manus treated with 1-week itraconazole vs. terbinafine.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Prospective Studies; Terbinafine; Tinea; Treatment Outcome | 2000 |
Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Topics: Age Factors; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Compliance; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Topics: Antifungal Agents; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine | 2001 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis.
Topics: Antifungal Agents; Antigens, CD19; CD3 Complex; CD4 Antigens; Epidermophyton; Foot Dermatoses; Hand Dermatoses; HLA-DR Antigens; Humans; Itraconazole; Killer Cells, Natural; Lymphocyte Count; Lymphocyte Subsets; Naphthalenes; Onychomycosis; Salicylates; Terbinafine; Trichophyton | 2001 |
Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Longitudinal Studies; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Retreatment; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2002 |
Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2002 |
An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Methylprednisolone; Middle Aged; Naphthalenes; Paronychia; Probability; Terbinafine; Treatment Outcome | 2002 |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Prospective Studies; Skin; Terbinafine; Tinea; Treatment Outcome | 2004 |
[Assessment of mycological and clinical factors on the course and results of treatment of mycotic infections in patients with recurrent onychomycosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Epidermophyton; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pentoxifylline; Recurrence; Terbinafine; Treatment Outcome; Trichophyton | 2003 |
A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Female; Foot Dermatoses; Gastrointestinal Diseases; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Patient Dropouts; Pilot Projects; Pruritus; Species Specificity; Terbinafine; Treatment Outcome | 2005 |
Study of oral itraconazole and terbinafine pulse therapy in onychomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Chi-Square Distribution; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 2006 |
[Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis].
Topics: Administration, Oral; Age Factors; Antifungal Agents; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Patient Compliance; Surveys and Questionnaires; Terbinafine | 2005 |
Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Topics: Antifungal Agents; Diabetes Complications; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Pulse Therapy, Drug; Terbinafine; Treatment Outcome | 2006 |
Assessment of the treatment protocol described in the guidelines for Trichophyton tonsurans infection.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Child; Hair Preparations; Humans; Itraconazole; Male; Miconazole; Naphthalenes; Patient Compliance; Practice Guidelines as Topic; Terbinafine; Tinea; Trichophyton | 2008 |
Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis.
Topics: Adult; Aged; Antifungal Agents; Case-Control Studies; Cohort Studies; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Young Adult | 2011 |
A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Topics: Adolescent; Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; China; Female; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2011 |
Histopathological periodic acid-schiff stains of nail clippings as a second-line diagnostic tool in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Glycogen; Humans; Itraconazole; Male; Middle Aged; Mycology; Nails; Naphthalenes; Onychomycosis; Periodic Acid-Schiff Reaction; Terbinafine; Treatment Outcome; Young Adult | 2012 |
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Antifungal Agents; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Genotype; Humans; Itraconazole; Male; Naphthalenes; Neuropsychological Tests; Terbinafine; Tramadol; Young Adult | 2015 |
Treatment of Onychomycosis - a Clinical Study.
Topics: Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Pyridones; Terbinafine | 2015 |
Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
Topics: Adult; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2016 |
Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (Erinaceus europaeus).
Topics: Administration, Oral; Animals; Antifungal Agents; Female; Hedgehogs; Itraconazole; Male; Naphthalenes; Terbinafine; Tinea | 2016 |
Plasma Concentrations of Itraconazole, Voriconazole, and Terbinafine When Delivered by an Impregnated, Subcutaneous Implant in Japanese Quail ( Coturnix japonica ).
Topics: Animals; Antifungal Agents; Coturnix; Dose-Response Relationship, Drug; Drug Implants; Itraconazole; Male; Naphthalenes; Pilot Projects; Subcutaneous Absorption; Terbinafine; Voriconazole | 2017 |
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Naphthalenes; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
Topics: Antifungal Agents; Humans; Itraconazole; Prospective Studies; Terbinafine; Tinea | 2021 |
Evaluation of the efficacy and safety of Unani Formulations in Pityriasis Versicolor: A randomized controlled trial.
Topics: Antifungal Agents; Child, Preschool; Humans; Immunoglobulin A; Infant; Itraconazole; Terbinafine; Tinea Versicolor; Treatment Outcome | 2022 |
321 other study(ies) available for itraconazole and terbinafine
| Article | Year |
|---|---|
Azoles, allylamines and drug metabolism.
Topics: Antifungal Agents; Azoles; Cyclosporine; Dose-Response Relationship, Drug; Humans; Hydrocortisone; In Vitro Techniques; Itraconazole; Ketoconazole; Microsomes, Liver; Naphthalenes; Terbinafine | 1992 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
Topics: Adult; Antifungal Agents; Cyclosporine; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Naphthalenes; Terbinafine | 1991 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole; Mice; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 1988 |
In-vitro studies with SF 86-327, a new orally active allylamine derivative.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Aspergillus; Blastomyces; Candida; Culture Media; Drug Resistance, Microbial; Fungi; Histoplasma; Itraconazole; Ketoconazole; Naphthalenes; Species Specificity; Sporothrix; Terbinafine | 1985 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
[Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Topics: Antifungal Agents; Cost-Benefit Analysis; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Antidermatophytic activity of allylamine derivatives.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1994 |
The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Disease Models, Animal; Female; Fluconazole; Guinea Pigs; Hair; Itraconazole; Naphthalenes; Skin Temperature; Terbinafine; Tinea; Treatment Outcome | 1994 |
[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Oxygenases; Terbinafine; Toes | 1994 |
[Fungal infections of the facial skin].
Topics: Adult; Facial Dermatoses; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Oxygenases; Terbinafine; Tinea; Trichophyton | 1994 |
Evaluation of antifungal effects of terbinafine and itraconazole using neutral red staining.
Topics: Antifungal Agents; Evaluation Studies as Topic; Itraconazole; Mycology; Naphthalenes; Neutral Red; Terbinafine; Trichophyton | 1994 |
Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
Topics: Antifungal Agents; Arthrodermataceae; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Morpholines; Naphthalenes; Terbinafine | 1994 |
New drugs for the nail fungus prevalent in elderly.
Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals.
Topics: Antifungal Agents; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prognosis; Terbinafine | 1996 |
New therapies for onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Plantar infection by Scopulariopsis brevicaulis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Erythema; Female; Foot Dermatoses; Humans; Imidazoles; Itraconazole; Mitosporic Fungi; Naphthalenes; Onychomycosis; Pruritus; Recurrence; Terbinafine | 1996 |
Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Topics: Algorithms; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Trees; Drug Administration Schedule; Drug Costs; Evaluation Studies as Topic; Follow-Up Studies; Foot Dermatoses; Germany; Health Resources; Humans; Itraconazole; Meta-Analysis as Topic; Naphthalenes; Onychomycosis; Paint; Practice Patterns, Physicians'; Pyridones; Sensitivity and Specificity; Terbinafine | 1996 |
Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine; Toes; Treatment Outcome | 1996 |
Onychomycosis. New therapies for an old disease.
Topics: Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 1996 |
Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy.
Topics: Adult; Antifungal Agents; Humans; Itraconazole; Male; Mycetoma; Naphthalenes; Pseudallescheria; Terbinafine | 1997 |
Effect of Lamisil and azole antifungals in experimental nail infection.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Candidiasis; Dermatomycoses; Dose-Response Relationship, Drug; Fingers; Humans; In Vitro Techniques; Itraconazole; Microscopy, Electron; Models, Theoretical; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Trichophyton | 1997 |
Dermatology.
Topics: 2-Aminopurine; Acyclovir; Antifungal Agents; Antiviral Agents; Dermatologic Agents; Dermatology; Dermatomycoses; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Itraconazole; Nail Diseases; Naphthalenes; Prodrugs; Skin Diseases; Terbinafine; Valacyclovir; Valine | 1997 |
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida albicans; Drug Interactions; Drug Therapy, Combination; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1997 |
Onychomycosis--a different perspective.
Topics: Antifungal Agents; Arthrodermataceae; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 1997 |
[How I treat onychomycosis using pulsed therapy].
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Nail Diseases; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Contempo 1997: dermatology.
Topics: Antifungal Agents; Contraceptives, Oral; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Tinea corporis due to Trichophyton tonsurans Malmsten--report of a patient from Zaire.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Betamethasone; Clotrimazole; Democratic Republic of the Congo; Female; Humans; Itraconazole; Naphthalenes; Recurrence; Terbinafine; Tinea; Trichophyton | 1997 |
Unusual clinical features of fingernail infection by Fusarium oxysporum.
Topics: Adult; Aged; Antifungal Agents; Female; Fusarium; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1998 |
Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Granulomatous skin infection caused by Scopulariopsis brevicaulis.
Topics: Adolescent; Antifungal Agents; Dermatomycoses; Female; Granuloma; Humans; Itraconazole; Mitosporic Fungi; Naphthalenes; Skin; Skin Diseases, Infectious; Terbinafine | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Spain; Terbinafine | 1998 |
Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Topics: Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Recurrence; Terbinafine; Time Factors; Tinea; Tinea Pedis; Toes; Trichophyton | 1998 |
In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.
Topics: Antifungal Agents; Ascomycota; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1998 |
[Limits of brief treatment of onychomycoses].
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Treatment Failure; Trichophyton | 1998 |
Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child.
Topics: Anti-Infective Agents; Cellulitis; Child, Preschool; Facial Dermatoses; Head; Humans; Infections; Itraconazole; Male; Naphthalenes; Neck; Pythium; Radiography; Terbinafine | 1998 |
Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Dermatomycoses; Humans; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Retrospective Studies; Switzerland; Terbinafine; Tinea Capitis; Trichophyton | 1998 |
Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Fusarium; Humans; Intertrigo; Itraconazole; Male; Microscopy, Electron, Scanning; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
[Synergistic effects of terbinafine and itraconazole antimycotics].
Topics: Antifungal Agents; Dermatomycoses; Drug Synergism; Humans; Itraconazole; Naphthalenes; Terbinafine | 1999 |
A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Topics: Antifungal Agents; Clinical Laboratory Techniques; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Griseofulvin; Health Maintenance Organizations; Humans; Itraconazole; Naphthalenes; New Jersey; Onychomycosis; Outcome Assessment, Health Care; Recurrence; Terbinafine; Transaminases | 1997 |
Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Topics: Antifungal Agents; Costs and Cost Analysis; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1998 |
Oral treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Reproducibility of Results; Terbinafine; Treatment Outcome | 1999 |
Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Prospective Studies; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 1999 |
Update on superficial fungal infections. Introduction.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Safety of itraconazole pulse therapy for onychomycosis. An update.
Topics: Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Liver Function Tests; Naphthalenes; Onychomycosis; Pregnancy; Terbinafine | 1999 |
The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Diagnosis, Differential; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.
Topics: Ascomycota; Drug Interactions; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2000 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.
Topics: Antifungal Agents; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Penicillium; Terbinafine | 2000 |
Coffee grinders assist pediatric dosing.
Topics: Administration, Oral; Antifungal Agents; Child; Child, Preschool; Dosage Forms; Drug Delivery Systems; Humans; Infant; Itraconazole; Naphthalenes; Powders; Solutions; Terbinafine; Tinea Capitis | 2000 |
Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Onychomycosis treated until the nail is replaced by normal growth or there is failure.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Clinical picture. Cutaneous hyalohyphomycosis.
Topics: Adult; Antifungal Agents; Dermatomycoses; Female; Fusarium; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
Case report: chronic dermatophyte infection in a patient with vitiligo and discoid lupus erythematosus.
Topics: Adult; Dermatomycoses; Humans; Itraconazole; Lupus Erythematosus, Discoid; Male; Naphthalenes; Recurrence; Terbinafine; Vitiligo | 2000 |
The implications and management of drug interactions with itraconazole, fluconazole and terbinafine.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
Amino acid- or protein-dependent growth of Trichophyton mentagrophytes and Trichophyton rubrum.
Topics: Amino Acids; Antifungal Agents; Culture Media; Electrophoresis, Polyacrylamide Gel; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Proteins; Terbinafine; Trichophyton | 2000 |
Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice.
Topics: Animals; Antifungal Agents; Itraconazole; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Naphthalenes; Terbinafine; Treatment Outcome | 2000 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[What's new in diagnosis and therapy of dermatomycoses in childhood].
Topics: Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Griseofulvin; Humans; Infant; Itraconazole; Malassezia; Naphthalenes; Terbinafine | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2001 |
[Keratosic knee nodule].
Topics: Aged; Antifungal Agents; Biopsy; Chromoblastomycosis; Cladosporium; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; French Guiana; Humans; Hypertension; Itraconazole; Knee; Naphthalenes; Terbinafine | 2001 |
Itraconazole, terbinafine possibly linked to liver failure.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Humans; Itraconazole; Naphthalenes; Terbinafine | 2001 |
Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum.
Topics: Antifungal Agents; Clotrimazole; Culture Media; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sensitivity and Specificity; Terbinafine; Trichophyton | 2002 |
Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis.
Topics: Administration, Oral; Animals; Antifungal Agents; Cat Diseases; Cats; Dermatomycoses; Female; Griseofulvin; Itraconazole; Male; Microsporum; Naphthalenes; Terbinafine; Treatment Outcome | 1999 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.
Topics: Absidia; Amphotericin B; Animals; Antifungal Agents; Brain; Female; Itraconazole; Kidney; Mice; Microbial Sensitivity Tests; Mucorales; Naphthalenes; Rhizopus; Survival Analysis; Terbinafine; Zygomycosis | 2002 |
[Diversified treatments of Tinea unguium].
Topics: Administration, Oral; Antifungal Agents; Combined Modality Therapy; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Occlusive Dressings; Onychomycosis; Pulse Therapy, Drug; Terbinafine | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
[Pharmacoeconomic approach to onychomycosis therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Military Personnel; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.
Topics: Adult; Antifungal Agents; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Paracoccidioides; Paracoccidioidomycosis; Terbinafine | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; DNA-Binding Proteins; Enzyme Inhibitors; Flucytosine; Fungal Proteins; Gene Expression Regulation, Fungal; Histone Deacetylase Inhibitors; Hydroxamic Acids; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Sterols; Terbinafine; Transcription Factors; Up-Regulation | 2002 |
Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Clotrimazole; Culture Media; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Reproducibility of Results; Temperature; Terbinafine | 2002 |
Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
Topics: Adult; Antifungal Agents; Chromoblastomycosis; Drug Therapy, Combination; Female; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Terbinafine | 2002 |
[A frequently underestimated dermatomycosis. Long-term therapeutic success with fungicidal effect].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Administration Schedule; Follow-Up Studies; Humans; Itraconazole; Long-Term Care; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2002 |
In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cladosporium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
Fungal nail infection: assessing the new treatment options.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Immunocompromised Host; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
Guidelines for treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Dermatomycoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Failure | 2003 |
In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Drug Interactions; Female; Fungi; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Sensitivity and Specificity; Terbinafine | 2003 |
Effect of itraconazole and terbinafine on Leishmania promastigotes.
Topics: Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Itraconazole; Leishmania donovani; Leishmania major; Leishmania mexicana; Naphthalenes; Terbinafine; Time Factors | 2003 |
Tinea capitis in Brussels: epidemiology and new management strategy.
Topics: Adolescent; Antifungal Agents; Belgium; Child; Child, Preschool; Drug Combinations; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Naphthalenes; Prevalence; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Terbinafine | 2003 |
In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Exophiala; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2003 |
[What is your diagnosis? Tinea capitis].
Topics: Antifungal Agents; Child; Clinical Trials as Topic; Diagnosis, Differential; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Terbinafine; Time Factors; Tinea Capitis | 2003 |
Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Antifungal Agents; Azoles; Candida; Cyclic AMP; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genotype; Imines; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Naphthalenes; Protein Synthesis Inhibitors; Saccharomyces cerevisiae; Signal Transduction; Sterols; Terbinafine; Up-Regulation | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Skin infection caused by Scedosporium apiospermum.
Topics: Adult; Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Scedosporium; Terbinafine | 2003 |
An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Probability; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Sex Factors; Terbinafine; Treatment Outcome | 2003 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
[Trichophyton violaceum infection in three black brothers].
Topics: Antifungal Agents; Black People; Child; Child, Preschool; Humans; Itraconazole; Male; Naphthalenes; Siblings; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2004 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole | 2004 |
Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine | 2004 |
In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
Topics: Antifungal Agents; Aspergillus; Ear Canal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2004 |
In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.
Topics: Animals; Antifungal Agents; Cats; Horses; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine | 2004 |
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes | 2004 |
Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Clotrimazole; Drug Resistance, Fungal; Epidermophyton; Humans; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Reagent Kits, Diagnostic; Terbinafine; Trichophyton | 2005 |
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
Topics: Animals; Antifungal Agents; Dermatologic Agents; Guinea Pigs; Imidazoles; Itraconazole; Mice; Mitosporic Fungi; Mycoses; Naphthalenes; Stereoisomerism; Structure-Activity Relationship; Terbinafine; Triazoles | 2005 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Scutular tinea of the scrotum: report of two cases.
Topics: Adult; Antifungal Agents; Genital Diseases, Male; HIV Infections; Humans; Immunocompetence; Itraconazole; Male; Microsporum; Middle Aged; Naphthalenes; Scrotum; Terbinafine; Tinea | 2005 |
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propolis; Terbinafine; Trichophyton; Turkey | 2005 |
In vitro susceptibility testing of Microsporum gypseum isolated from healthy cattle and soil samples against itraconazole, terbinafine, fluconazole and topical veterinarian drugs.
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Cattle; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Soil Microbiology; Terbinafine; Veterinary Drugs | 2005 |
Images in clinical medicine. Chromoblastomycosis.
Topics: Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Leg; Male; Naphthalenes; Terbinafine | 2005 |
[Physiological comportment and in vivo sensitivity of Sporothrix schenckii isolates maintained for 18 years by two preservation methods].
Topics: Agar; Antifungal Agents; Drug Resistance, Fungal; Glucose; Itraconazole; Microbial Sensitivity Tests; Mycology; Naphthalenes; Potassium Iodide; Preservation, Biological; Sporothrix; Starch; Terbinafine; Time Factors; Triazoles; Water | 2005 |
[In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
Topics: Antifungal Agents; Cheek; Dermatomycoses; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Naphthalenes; Scalp; Terbinafine | 2005 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
[Current treatment recommendations in tinea corporis?].
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 2006 |
[The susceptibility of Aspergillus and Penicillium to recent antimycotics].
Topics: Antifungal Agents; Aspergillus; Ciclopirox; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Penicillium; Pyridones; Terbinafine | 2000 |
Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Ascomycota; Cell Proliferation; Chromoblastomycosis; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Itraconazole; Male; Middle Aged; Naphthalenes; T-Lymphocytes; Terbinafine; Tumor Necrosis Factor-alpha | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton | 2006 |
In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Dogs; Horses; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Naphthalenes; Sporothrix; Terbinafine; Yeasts | 2006 |
Tinea capitis.
Topics: Administration, Oral; Adult; Anti-Infective Agents, Local; Antifungal Agents; Child; Diagnosis, Differential; Double-Blind Method; Griseofulvin; Humans; Itraconazole; Naphthalenes; Povidone-Iodine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Soaps; Terbinafine; Time Factors; Tinea Capitis; Treatment Outcome | 2006 |
Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Nails, Ingrown; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine; Treatment Outcome | 2007 |
Comparison of the effects of three different anti-fungus drugs on Candida albicans of murine vaginal mucosa.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Itraconazole; Mice; Mice, Inbred ICR; Naphthalenes; Random Allocation; Terbinafine; Treatment Outcome; Vagina | 2007 |
Cutaneous phaeohyphomycosis due to Cladophialophora bantiana in an immunocompetent patient.
Topics: Antifungal Agents; Cladosporium; Dermatomycoses; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Itraconazole; Middle Aged; Naphthalenes; Opportunistic Infections; Terbinafine; Treatment Outcome | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole | 2008 |
Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2008 |
Cutaneous infection caused by Curvularia species in an immunocompetent patient.
Topics: Aged; Antifungal Agents; Dermatomycoses; Forearm; Humans; Immunocompetence; Itraconazole; Male; Naphthalenes; Terbinafine; Treatment Outcome | 2008 |
Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Culture Media; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine | 2008 |
In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Topics: Amphotericin B; Analysis of Variance; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Drug Interactions; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Phialophora; Terbinafine | 2008 |
Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Topics: Adult; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Drug Therapy, Combination; Face; Humans; Itraconazole; Leg Dermatoses; Male; Middle Aged; Naphthalenes; Terbinafine; Treatment Outcome | 2009 |
In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Topics: Amphotericin B; Antifungal Agents; Corneal Diseases; Drug Evaluation; Drug Synergism; Eye; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Natamycin; Terbinafine | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
Rhinofacial Conidiobolus coronatus infection presenting with nasal enlargement.
Topics: Adult; Antifungal Agents; Conidiobolus; Emigrants and Immigrants; Face; Humans; Itraconazole; Magnetic Resonance Imaging; Male; Naphthalenes; Nose; Nose Deformities, Acquired; Sudan; Terbinafine; Young Adult; Zygomycosis | 2008 |
Trichophyton species susceptibility to green and red propolis from Brazil.
Topics: Antifungal Agents; Brazil; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Naphthalenes; Propolis; Terbinafine; Trichophyton | 2009 |
Onychomycosis: therapy directed by morphology and mycology.
Topics: Antifungal Agents; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2009 |
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2009 |
[Summarization of tinea capitis cases encountered at a clinic in the past 5 years].
Topics: Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Female; Humans; Itraconazole; Male; Microsporum; Middle Aged; Naphthalenes; Practice Guidelines as Topic; Terbinafine; Time Factors; Tinea Capitis; Treatment Outcome; Trichophyton | 2009 |
Chromoblastomycosis in Sarawak, East malaysian Borneo.
Topics: Adult; Aged; Antifungal Agents; Biopsy; Borneo; Chromoblastomycosis; Cryotherapy; Electrocoagulation; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Retrospective Studies; Terbinafine; Treatment Outcome | 2010 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Chromoblastomycosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Diagnosis, Differential; Humans; Itraconazole; Male; Naphthalenes; Skin; Terbinafine | 2010 |
A new species, Aspergillus persii, as an agent of onychomycosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2010 |
A dark strain in the Fusarium solani species complex isolated from primary subcutaneous sporotrichioid lesions associated with traumatic inoculation via a rose bush thorn.
Topics: Adult; Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Drug Therapy, Combination; Fungal Proteins; Fusarium; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Naphthalenes; Pigments, Biological; RNA Polymerase II; Sequence Analysis, DNA; Skin; Spores, Fungal; Sporotrichosis; Terbinafine; Treatment Outcome; Wound Infection | 2010 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome | 2010 |
Commentary: the illusory tinea unguium cure.
Topics: Aged; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Trichophyton | 2010 |
Quantitative analysis of the effects of antimycotic agents on the hyphal growth of Trichophyton rubrum: a preliminary study.
Topics: Antifungal Agents; Culture Media; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Microscopy, Video; Naphthalenes; Terbinafine; Time Factors; Trichophyton | 2011 |
Identification and characterisation of human pathogenic filamentous fungi and susceptibility to Thymus schimperi essential oil.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Fungal; Fungal Proteins; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Mycoses; Naphthalenes; Oils, Volatile; Sequence Analysis, DNA; Terbinafine; Thymus Plant | 2011 |
In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.
Topics: Administration, Topical; Animals; Antifungal Agents; Candida albicans; Dermatitis; Female; Guinea Pigs; Humans; Imidazoles; Inhibitory Concentration 50; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Triazoles; Vaginitis | 2010 |
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2010 |
The antimycotic drugs itraconazole and terbinafine hydrochloride induce the production of human β-defensin-3 in human keratinocytes.
Topics: Antifungal Agents; beta-Defensins; Cells, Cultured; Culture Media, Conditioned; Gene Expression Regulation; Humans; Itraconazole; Keratinocytes; Naphthalenes; Phosphorylation; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Terbinafine; Thromboxane B2; Transcription Factor AP-1 | 2011 |
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Environmental Microbiology; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mucorales; Mucormycosis; Mycological Typing Techniques; Naphthalenes; Peptide Elongation Factor 1; Phylogeny; Sequence Analysis, DNA; Spores, Fungal; Temperature; Terbinafine; Triazoles | 2010 |
Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in collagen disease patient.
Topics: Aged, 80 and over; Antifungal Agents; Collagen Diseases; Dermatomycoses; Exophiala; Humans; Immunocompromised Host; Itraconazole; Male; Naphthalenes; Terbinafine | 2010 |
Successful management of gastrointestinal pythiosis in a dog using itraconazole, terbinafine, and mefenoxam.
Topics: Alanine; Animals; Antifungal Agents; Dog Diseases; Dogs; Duodenum; Female; Gastrointestinal Diseases; Histocytochemistry; Itraconazole; Naphthalenes; Pythiosis; Pythium; Terbinafine; Treatment Outcome | 2011 |
In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Triazoles | 2011 |
[Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
Topics: Antifungal Agents; Econazole; Hair; Hemolysis; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Skin; Terbinafine; Tinea; Trichophyton | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Infant sporotrichosis in northeast China: a report of 15 cases.
Topics: Antifungal Agents; China; Drug Therapy, Combination; Face; Female; Granuloma; Humans; Infant; Itraconazole; Male; Naphthalenes; Potassium Iodide; Retrospective Studies; Sporothrix; Sporotrichosis; Terbinafine; Treatment Outcome | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
[Tinea capitis in elderly women: a report of 4 cases].
Topics: Age of Onset; Aged; Antifungal Agents; Diagnostic Errors; Eczema; Female; Humans; Itraconazole; Naphthalenes; Skin Diseases, Bacterial; Terbinafine; Tinea Capitis; Trichophyton | 2012 |
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
Topics: Antifungal Agents; Arm; Ascomycota; Child; Chromoblastomycosis; Chronic Disease; Histocytochemistry; Humans; India; Itraconazole; Male; Microscopy; Mycology; Naphthalenes; Terbinafine; Treatment Outcome | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Diagnosis and treatment of truncal cutaneous pythiosis in a dog.
Topics: Animals; Antibodies; Antifungal Agents; Dog Diseases; Dogs; Female; Itraconazole; Naphthalenes; Pythiosis; Pythium; Terbinafine | 2011 |
Cutaneous phaeohyphomycosis caused by Exophiala spinifera in a patient with systemic lupus erythematosus.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Exophiala; Female; Humans; Itraconazole; Lupus Erythematosus, Systemic; Microscopy; Naphthalenes; Phaeohyphomycosis; Sequence Analysis, DNA; Terbinafine | 2012 |
In vitro and in vivo susceptibility of two-drug and three-drug combinations of terbinafine, itraconazole, caspofungin, ibuprofen and fluvastatin against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Caspofungin; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fatty Acids, Monounsaturated; Fluvastatin; Ibuprofen; Indoles; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Naphthalenes; Pythiosis; Pythium; Rabbits; Terbinafine | 2012 |
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2012 |
In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
Treatment outcomes for tinea capitis in a skin of color population.
Topics: Adolescent; Age Factors; Antifungal Agents; Black or African American; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluconazole; Follow-Up Studies; Griseofulvin; Hispanic or Latino; Humans; Infant; Itraconazole; Male; Naphthalenes; New York City; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome; Urban Population; White People | 2012 |
Treatment of intestinal pythiosis in a dog with a combination of marginal excision, chemotherapy, and immunotherapy.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Intestinal Diseases; Itraconazole; Male; Naphthalenes; Pythiosis; Pythium; Terbinafine; Vaccines | 2012 |
Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
Annular rash outbreak in a family.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Child; Diagnosis, Differential; Disease Outbreaks; Exanthema; Family; Female; Humans; Itraconazole; Male; Microsporum; Naphthalenes; Pets; Terbinafine; Tinea | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
In vitro interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection.
Topics: Amantadine; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Selegiline; Terbinafine; Valproic Acid | 2012 |
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon | 2013 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure | 2014 |
[Generalized chromomycosis caused by Phialophora verrucosa].
Topics: Adult; Amphotericin B; Antifungal Agents; Arm; Chromoblastomycosis; Clarithromycin; Diabetes Complications; Diagnosis, Differential; Female; Hand Dermatoses; Humans; Itraconazole; Leishmaniasis, Cutaneous; Morocco; Naphthalenes; Phialophora; Terbinafine; Tuberculosis, Cutaneous | 2013 |
Drug combinations against Mucor irregularis in vitro.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles | 2013 |
The first case of phaeohyphomycosis caused by Rhinocladiella basitona in an immunocompetent child in China.
Topics: Antifungal Agents; Ascomycota; Child; China; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Face; Female; Histocytochemistry; Humans; Itraconazole; Microbiological Techniques; Molecular Diagnostic Techniques; Molecular Sequence Data; Naphthalenes; Phaeohyphomycosis; Sequence Analysis, DNA; Terbinafine | 2013 |
[Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].
Topics: Acremonium; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusariosis; Fusarium; Humans; Itraconazole; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Reproducibility of Results; Terbinafine | 2013 |
Clinical improvement of chromoblastomycosis refractory to itraconazole successfully treated with high dose of terbinafine.
Topics: Aged; Antifungal Agents; Chromoblastomycosis; Humans; Itraconazole; Male; Naphthalenes; Terbinafine; Treatment Failure | 2013 |
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Epidermophyton; Griseofulvin; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton; Turkey | 2013 |
[Photo quiz: Dermatomycosis].
Topics: Administration, Oral; Antifungal Agents; Candida albicans; Candidiasis, Cutaneous; Diagnostic Errors; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Failure; Treatment Outcome | 2013 |
Cutaneous pythiosis in two dogs from Wisconsin, USA.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Dog Diseases; Dogs; Female; Immunotherapy; Itraconazole; Male; Molecular Sequence Data; Naphthalenes; Prednisone; Pythiosis; Pythium; RNA, Ribosomal; Terbinafine; Wisconsin | 2014 |
Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.
Topics: Administration, Oral; Adult; Arthrodermataceae; Cohort Studies; DNA, Fungal; Drug Therapy, Combination; Female; Fusarium; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Retrospective Studies; Severity of Illness Index; Terbinafine; Treatment Failure; Trichophyton | 2014 |
Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.
Topics: Antifungal Agents; Ciclopirox; Drug Resistance, Fungal; Ergosterol; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Pyridones; Terbinafine; Trichophyton | 2014 |
A rare case of subcutaneous phaeohyphomycosis caused by a Rhytidhysteron species: a clinico-therapeutic experience.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Liposomes; Male; Mycoses; Naphthalenes; Phaeohyphomycosis; Terbinafine | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; Chromoblastomycosis; Drug Therapy, Combination; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Skin; Terbinafine; Treatment Outcome; Voriconazole | 2015 |
In vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis.
Topics: Azoles; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2015 |
Phaeohyphomycosis caused by Exophiala spinifera: an increasing disease in young females in mainland China? Two case reports and review of five cases reported from mainland China.
Topics: Administration, Oral; Adolescent; Antifungal Agents; China; Drug Therapy, Combination; Exophiala; Female; Humans; Itraconazole; Naphthalenes; Phaeohyphomycosis; Pregnancy; Pregnancy Complications, Infectious; Terbinafine; Young Adult | 2015 |
[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Itraconazole; Naphthalenes; Terbinafine; Thiazoles; Triazoles | 2014 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Arthrodermataceae; Colony Count, Microbial; Dermatomycoses; Drug Synergism; Fluconazole; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Naphthalenes; Terbinafine | 2014 |
Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Topics: Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Recurrence; Terbinafine; Treatment Outcome | 2015 |
CHROMOBLASTOMYCOSIS MASQUERADING AS DERMATOPHYTOSIS, WITH THE DESCRIPTION OF A NEW OPPORTUNISTIC SPECIES.
Topics: Antifungal Agents; Ascomycota; Biopsy; Chromoblastomycosis; Diagnosis, Differential; Face; Female; Humans; Itraconazole; Middle Aged; Naphthalenes; Species Specificity; Terbinafine; Thailand; Tinea | 2015 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Darier Disease Complicated by Terbinafine-resistant Trichophyton rubrum: A Case Report.
Topics: Antifungal Agents; Darier Disease; Drug Resistance, Fungal; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Terbinafine; Tinea; Trichophyton | 2017 |
A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
Topics: Adult; Animals; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Ribosomal; DNA, Ribosomal Spacer; Ear Auricle; Humans; Itraconazole; Male; Naphthalenes; Phylogeny; Sequence Analysis, DNA; Siphonaptera; Terbinafine | 2016 |
A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Diagnostic Techniques; Naphthalenes; Penile Diseases; Recurrence; Terbinafine; Treatment Outcome | 2017 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluconazole; Glycated Hemoglobin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Prevalence; Sex Factors; Terbinafine; Tinea Pedis; Toes; Trichophyton; Turkey | 2017 |
Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Detergents; Diabetes Complications; Eczema; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Hypertension; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Risk Factors; Soil; Terbinafine; Time-to-Treatment; Treatment Outcome; Water; Young Adult | 2017 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; Ketoconazole; Malaysia; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2017 |
Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Drug Therapy, Combination; Itraconazole; Larva; Madurella; Moths; Mycetoma; Naphthalenes; Terbinafine | 2017 |
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Terbinafine; Triazoles | 2017 |
In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Cat Diseases; Cats; Itraconazole; Life Cycle Stages; Microbial Sensitivity Tests; Mycelium; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Tinea corporis presenting as disseminated verrucous plaques caused by Arthroderma incurvatum in a young Indian boy.
Topics: Antifungal Agents; Arthrodermataceae; Child; Chronic Disease; Drug Therapy, Combination; Humans; India; Itraconazole; Male; Terbinafine; Tinea | 2017 |
Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Electrophoresis, Gel, Two-Dimensional; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Proteomics; RNA, Fungal; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Up-Regulation; Voriconazole | 2017 |
Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Electron Transport Complex I; Itraconazole; Lipid Peroxidation; Mitochondria; Mitochondrial Membranes; Naphthalenes; Oxidative Stress; Reactive Oxygen Species; Sulfhydryl Compounds; Terbinafine | 2017 |
Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Retrospective Studies; Secondary Prevention; Terbinafine | 2017 |
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.
Topics: Antifungal Agents; Case-Control Studies; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Psoriasis; Risk; Taiwan; Terbinafine | 2018 |
Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.
Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Histocytochemistry; Humans; Hyperthermia, Induced; Itraconazole; Male; Microscopy; Middle Aged; Molecular Diagnostic Techniques; Naphthalenes; Terbinafine; Treatment Outcome; Upper Extremity | 2018 |
Recurrent terbinafine resistant Trichophyton rubrum infection in a child with congenital ichthyosis.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Humans; Ichthyosiform Erythroderma, Congenital; Itraconazole; Male; Naphthalenes; Recurrence; Terbinafine; Tinea; Trichophyton | 2018 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
Clinicopathological features and outcomes of pythiosis.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Animals; Antifungal Agents; Female; Humans; Immunotherapy; Itraconazole; Male; Middle Aged; Naphthalenes; Pythiosis; Pythium; Retrospective Studies; Terbinafine; Thailand; Young Adult | 2018 |
An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Combined Modality Therapy; Cryotherapy; DNA, Fungal; DNA, Ribosomal Spacer; Genome, Fungal; Humans; Itraconazole; Male; Middle Aged; Sequence Analysis, DNA; Skin; Terbinafine; Treatment Outcome | 2018 |
Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Synergism; Humans; Imidazoles; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Morpholines; Species Specificity; Tacrolimus; Terbinafine; Triamcinolone Acetonide | 2018 |
An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data.
Topics: Adverse Drug Reaction Reporting Systems; Antifungal Agents; Computers; Databases, Factual; Humans; Itraconazole; Software; Terbinafine | 2019 |
Antifungal Susceptibility of Japanese Isolates of Nannizia fulva (Formerly Microsporum fulvum).
Topics: Animal Diseases; Animals; Antifungal Agents; Arthrodermataceae; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Itraconazole; Japan; Terbinafine; Tinea | 2019 |
Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biodiversity; Child; Child, Preschool; Female; Fluconazole; Fungi; Hong Kong; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nail Diseases; Onychomycosis; Phenotype; Phylogeny; Terbinafine; Young Adult | 2019 |
Successful management of 3 dogs with colonic pythiosis using itraconzaole, terbinafine, and prednisone.
Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Colon; Dog Diseases; Dogs; Gastrointestinal Diseases; Itraconazole; Prednisone; Pythiosis; Pythium; Serologic Tests; Terbinafine | 2019 |
A Revised Species Concept for Opportunistic
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Mucor; Mucormycosis; Natamycin; Nitriles; Pyridines; Rhizopus; Species Specificity; Terbinafine; Triazoles | 2019 |
Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Atherosclerosis; Female; Humans; Hyperlipidemias; Itraconazole; Logistic Models; Male; Middle Aged; Nails; Onychomycosis; Retrospective Studies; Severity of Illness Index; Terbinafine; Treatment Outcome | 2021 |
Effective treatment using itraconazole combined with terbinafine in the treatment of nasal sporotrichosis: A case report.
Topics: Antifungal Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Itraconazole; Middle Aged; Nose; Sporotrichosis; Terbinafine | 2019 |
Topics: Antifungal Agents; Base Sequence; Epidermophyton; Humans; Iran; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Trichophyton; Voriconazole | 2019 |
Scientific rationale of antifungal drug combination, including oral itraconazole and terbinafine, in recalcitrant dermatophytoses.
Topics: Antifungal Agents; Drug Combinations; Humans; Itraconazole; Terbinafine; Tinea | 2020 |
Antifungal combination therapy in dermatophytosis: a clinical insight.
Topics: Antifungal Agents; Combined Modality Therapy; Humans; Itraconazole; Terbinafine; Tinea | 2020 |
Retrospective two-centre study on prepubertal children with Tinea capitis in Korea.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child Health; Child, Preschool; Female; Humans; Incidence; Infant; Itraconazole; Male; Microsporum; Republic of Korea; Retrospective Studies; Seasons; Sex Distribution; Skin; Terbinafine; Tinea Capitis; Trichophyton | 2020 |
Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Photochemotherapy; Skin; Terbinafine; Voriconazole | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Epidemiological and clinical comparisons of paediatric and adult sporotrichosis in Jilin Province, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; China; Female; Humans; Infant; Itraconazole; Male; Middle Aged; Potassium Iodide; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Rural Population; Seasons; Sporotrichosis; Temperature; Terbinafine; Time Factors; Young Adult | 2020 |
In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Thiazoles; Triazoles | 2020 |
Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Skin; Terbinafine; Tinea; Treatment Outcome | 2020 |
Topics: Anti-Bacterial Agents; Antifungal Agents; Antiparasitic Agents; Azithromycin; Clarithromycin; Doxycycline; Humans; Itraconazole; Macrolides; Parasitic Sensitivity Tests; Pythiosis; Pythium; Terbinafine; Tetracyclines; Thailand | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
In vitro antifungal susceptibility testing of fungi in patients with onychomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Terbinafine | 2021 |
Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.
Topics: Antifungal Agents; Humans; Itraconazole; Liver Transplantation; Onychomycosis; Terbinafine; Voriconazole | 2020 |
A call for antifungal stewardship.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
An Unusual Case of a Dematiaceous Fungus with an Exclusive Cerebral Involvement After ABO-Incompatible Renal Transplantation.
Topics: Ascomycota; Dermatomycoses; Humans; Itraconazole; Kidney Transplantation; Male; Middle Aged; Terbinafine | 2020 |
The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial.
Topics: Antifungal Agents; Arthrodermataceae; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine | 2021 |
Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar.
Topics: Adult; Aged; Antifungal Agents; Chromoblastomycosis; Female; Humans; Itraconazole; Madagascar; Male; Middle Aged; Prospective Studies; Terbinafine | 2020 |
Mefenoxam, Itraconazole, and Terbinafine Combination Therapy for Management of Pythiosis in Dogs (Six Cases).
Topics: 14-alpha Demethylase Inhibitors; Alanine; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Health Services Accessibility; Itraconazole; Male; Pythiosis; Skin Diseases, Parasitic; Terbinafine | 2020 |
Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus Fonsecaea monophora.
Topics: Amphotericin B; Antifungal Agents; Bacterial Proteins; Chromoblastomycosis; Fonsecaea; Gene Deletion; Genome, Fungal; Humans; Itraconazole; Melanins; Polyketide Synthases; Spores, Fungal; Terbinafine | 2021 |
THE ISOLATION AND ANTIMICROBIAL SENSITIVITY OF
Topics: Air Sacs; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Multiple, Fungal; Itraconazole; Lung; Species Specificity; Spheniscidae; Terbinafine; United Kingdom; Voriconazole | 2020 |
First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries.
Topics: Administration, Cutaneous; Antifungal Agents; Byssochlamys; Humans; Itraconazole; Mycetoma; Terbinafine; Treatment Outcome | 2021 |
Treatment of chromoblastomycosis with a combination of debulking surgery, intralesional amphotericin B, and oral terbinafine.
Topics: Amphotericin B; Antifungal Agents; Chromoblastomycosis; Cytoreduction Surgical Procedures; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine | 2021 |
Diagnosis, treatment, and outcome in a dog with systemic Mycoleptodiscus indicus infection.
Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Itraconazole; Male; Sepsis; Terbinafine; Treatment Outcome | 2021 |
The in vitro effect of nanoliposomal amphotericin B against two clinically important dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine | 2022 |
Topics: Antifungal Agents; Arthrodermataceae; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2022 |
Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients.
Topics: Administration, Topical; Aged; Antifungal Agents; Humans; Itraconazole; Medicare; Onychomycosis; Prescriptions; Terbinafine; United States | 2022 |
Vascular pythiosis caused by Pythium aphanidermatum: the first case report in Asia.
Topics: Antifungal Agents; Azithromycin; Fatal Outcome; Female; Host-Pathogen Interactions; Humans; Hyphae; Itraconazole; Middle Aged; Pythiosis; Pythium; Terbinafine; Thailand; Thrombosis | 2021 |
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Triazoles | 2022 |
Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.
Topics: Antifungal Agents; Azoles; Exophiala; Humans; Itraconazole; Phaeohyphomycosis; Terbinafine; Voriconazole | 2022 |
A deletion mutation in the amino acid sequence of squalene epoxidase in terbinafine-resistant Trichophytonrubrum.
Topics: Amino Acid Sequence; Antifungal Agents; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Sequence Deletion; Squalene Monooxygenase; Terbinafine; Trichophyton | 2022 |
Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing.
Topics: Antifungal Agents; Arthrodermataceae; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Lipase; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Phylogeny; Terbinafine; Tinea; Vietnam; Voriconazole | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Quantitative analysis of in vitro biofilm formation by clinical isolates of dermatophyte and antibiofilm activity of common antifungal drugs.
Topics: Antifungal Agents; Arthrodermataceae; Biofilms; Griseofulvin; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Trichophyton | 2023 |
Multidrug resistant tinea corporis/cruris: Response to voriconazole.
Topics: Antifungal Agents; Humans; Itraconazole; Terbinafine; Tinea; Tinea cruris; Voriconazole | 2022 |
Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Brazil; Chromoblastomycosis; Diabetes Mellitus, Type 2; Humans; Itraconazole; Middle Aged; Molecular Epidemiology; Terbinafine; Voriconazole | 2022 |
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries.
Topics: Antifungal Agents; Developed Countries; Echinocandins; Humans; Itraconazole; Polyenes; Terbinafine | 2022 |
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Malaria; Microbial Sensitivity Tests; Phaeohyphomycosis; Terbinafine | 2022 |
PULMONARY AND COELOMIC MYCOSES DUE TO
Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole | 2022 |
Oral Terbinafine and Itraconazole Combined with Intralesional Amphotericin B Therapy Against Large Chromoblastomycosis Lesions.
Topics: Amphotericin B; Antifungal Agents; Chromoblastomycosis; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine | 2022 |
Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Psoriasis; Saccharomyces cerevisiae; Terbinafine | 2023 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |
Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Topics: Antifungal Agents; Child; Cohort Studies; Fluconazole; Humans; Itraconazole; Terbinafine; Tinea Capitis; United States | 2023 |
Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan.
Topics: Animals; Antifungal Agents; Canidae; Cats; Itraconazole; Japan; Terbinafine; Tinea | 2023 |
Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes - interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Proteomics; Terbinafine; Tinea; Transcriptional Regulator ERG; Trichophyton | 2023 |
Epidemiological study of antifungal-resistant dermatophytes isolated from Japanese patients.
Topics: Antifungal Agents; East Asian People; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
Topics: Amphotericin B; Animals; Antifungal Agents; China; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Prevalence; Sporothrix; Sporotrichosis; Terbinafine | 2023 |
Oral Terbinafine and Itraconazole Therapy Against Sporothrix brasiliensis an Emerging Species in Argentina.
Topics: Antifungal Agents; Argentina; Itraconazole; Microbial Sensitivity Tests; Sporothrix; Sporotrichosis; Terbinafine | 2023 |
The Domestic Isolation of Terbinafine- and Itraconazole-Resistant Trichophyton indotineae in Chinese Mainland.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Squalene Monooxygenase; Terbinafine; Trichophyton | 2023 |
Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; North America; Terbinafine; Trichophyton | 2023 |
A Falciformispora senegalensis grain model in Galleria mellonella larvae.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Humans; Itraconazole; Larva; Moths; Mycetoma; Terbinafine | 2023 |
Comparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis.
Topics: Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Terbinafine; Tinea; Treatment Outcome | 2023 |
In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Topics: Antifungal Agents; Azoles; Binding Sites; Databases, Factual; Fungi; Hydrogen Bonding; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2006 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Cations; Chlorides; Humans; Microbial Sensitivity Tests; Phosphorylcholine; Pyridinium Compounds; Quaternary Ammonium Compounds | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Topics: Amphotericin B; Antifungal Agents; DNA, Ribosomal Spacer; Microbial Sensitivity Tests; Mucorales; Triazoles | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
Synthesis and biological evaluation of (+)-labdadienedial, derivatives and precursors from (+)-sclareolide.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Chlorocebus aethiops; Diterpenes; Fungi; HeLa Cells; Herpesvirus 1, Human; Humans; Inhibitory Concentration 50; Vero Cells | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
Fluoride enhances the activity of fungicides that destabilize cell membranes.
Topics: Candida albicans; Cell Membrane; Cell Proliferation; Drug Synergism; Fluorides; Fungicides, Industrial; Humans; Polyenes | 2012 |
Evaluation of bioactivities of chlorokojic acid derivatives against dermatophytes couplet with cytotoxicity.
Topics: Antifungal Agents; Arthrodermataceae; Pyrones | 2013 |
Synthesis and antifungal activity of terpenyl-1,4-naphthoquinone and 1,4-anthracenedione derivatives.
Topics: Animals; Anthracenes; Antifungal Agents; Aspergillus; Candida; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Fusarium; Microbial Sensitivity Tests; Molecular Structure; Naphthoquinones; Structure-Activity Relationship; Trichophyton; Vero Cells | 2013 |
Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates.
Topics: Aspergillus fumigatus; Candida; Carbamates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation | 2014 |
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton | 2014 |
Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance.
Topics: Animals; Antifungal Agents; Aspergillus; Candida; Cell Line; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Fibroblasts; Fusarium; Hemolytic Agents; Humans; Inhibitory Concentration 50; Keratitis; Mice, Inbred C57BL; Microbial Sensitivity Tests; Structure-Activity Relationship; Xanthones | 2017 |
A new sulfated triterpene glycoside from the sea cucumber Colochirus quadrangularis, and evaluation of its antifungal, antitumor and immunomodulatory activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glycosides; Humans; Immunomodulation; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Saponins; Sea Cucumbers; Triterpenes | 2021 |